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Abstract
Nanopatterning of biomolecules on functionalized surfaces offers an ex-
cellent route for ultrasensitive protein immobilization, for interaction
measurements, and for the fabrication of devices such as protein nanoar-
rays. An improved understanding of the physics and chemistry under-
lying the device properties and the recognition process is necessary for
performance optimization. This is especially important for the recogni-
tion and immobilization of intrinsically disordered proteins (IDPs), like
the prion protein (PrP), a partial IDP, whose folding and stability may
be influenced by local environment and confinement.
Atomic force microscopy allows for both highly controllable nanolithog-
raphy and for sensitive and accurate direct detection, via precise to-
pographic measurements on ultra-flat surfaces, of protein interactions
in a liquid environment, thus different environmental parameters affect-
ing the biorecognition phenomenon can be investigated in situ. Using
nanografting, a tip-induced lithographic technique, and an affinity im-
mobilization strategy based on two different histidine tagged antibod-
ies, with high nM affinity for two different regions of PrP, we success-
fully demonstrated the immobilization of recombinant mouse PrP onto
nanostructured surfaces, in two different orientations. Clear discrimina-
tion of the two molecular orientations was shown by differential height
(i.e. topographic) measurements, allowing for the estimation of binding
parameters and the full characterization of the nanoscale biorecognition
process.
Our work opens the way to several high sensitivity diagnostic applica-
tions and, by controlling PrP orientation, allows for the investigation
of unconventional interactions with partially folded proteins, and may
serve as a platform for protein misfolding and refolding studies on PrP
and other thermodynamically unstable, fibril forming, proteins.
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1Background
The set of tools that the application of chemistry, physics and engineering, and,
in particular, nanotechnology, offers to proteomics and bioanalytical chemistry is a
powerful draw even for fundamental studies in the biophysics of interactions. The
most fascinating property of biological system is their ability to self-assemble with
remarkable specificity, robustness and predictability, and among the fundamental
building block of living cells proteins are a paradigmatic example of both intramolec-
ular (folding), and intermolecular (high-order protein architecture) self assembly.
Molecular hierarchical organization, together with the capability of molecular ma-
nipulation in the size range of 1÷100 nm, is the realm of application of nanotechnol-
ogy. Started as a sort of molecular level foundry, nanotechnology quickly trespassed
the traditional field of applied physics for energy and engineering development to
open new avenues for foreground investigation of biological systems. A plethora of
new techniques able to measure and manipulate submicrometric object down to the
single molecule level is now available for the study of biologically relevant processes,
like protein folding and protein-protein interactions.
In particular, systematic studies of protein-protein interactions have been tremen-
dously influenced by the introduction of protein-compatible surface nanostructures
on which functional and stable protein assemblies can be formed and character-
ized. Properly designed nanostructures combined with surface sensitive techniques,
above all Atomic Force Microscopy, offer unprecedented control over active proteins
immobilization at the nanoscale and their accurate biochemical characterization.
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The overall goal of the present thesis is the development of novel routes for oriented
immobilization of recombinant mouse prion protein molecules on a solid surface for
further morphological and biorecognition studies. One major outcome of this re-
search is also the expected development of effective diagnostic strategies for possible
early detection of prions in prion diseases. In addition to possible diagnostics appli-
cations, the strict control over PrP orientation opens many avenues of investigation
of possible interacting partners, from large macromolecular complexes to small or-
ganic dyes that interact unconventionally with unfolded proteins, and may serve
as a platform for protein misfolding studies on PrP and other thermodynamically
unstable proteins involved in so-called protein misfolding diseases. Among this class
of maladies, neurodegenerative diseases are surmised to profit from nanotechnolog-
ical based reliable detection and monitoring of molecular marker in non-invasive
approaches, as well as a nanoscale sensitivity to protein conformational changes,
protein interactions networks and, of course, protein fibrillation characterization.
Human neurodegenerative disorders are a broad class of pathological conditions
that manifest with progressive neurological function decline. The slow but irre-
versible cell loss in distinct areas of the CNS (Central Nervous System) dictates
the clinical presentation, as motor disorder in Parkinson Disease (PD), or cognitive
impairment in Alzheimer’s Disease (AD) and in Fronto Temporal Lobe Dementia
(FTLD), as an example. These maladies all share remarkably similar temporal
emergence patterns, even though different toxic proteins are involved in their onset.
Familial neurodegenerative diseases have an earlier emergence, typically in the fifth
decade of life, whereas sporadic cases do not exhibit symptoms earlier than the sev-
enth decade.
Clinical presentation is only one part of the classical nosological classification
of neurodegenderative diseases. Characterization of the anatomical regions and cell
types affected, aetiology (i.e. genetic defects), and conformationally altered proteins
involved in the pathogenetic process, all are instrumental in a detailed diagnosis, that
in almost all cases can be confirmed only in the post-mortem.
Histological samples from affected tissues present insoluble but highly ordered
deposits, referred to as amyloids, of specific proteins. This deposits, which high
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supramolecular order is incredibly similar despite the original protein involved, arise
from a structural transition, a conformational change from a physiological to an
altered state that results in protein dysfunction and potentially toxic intra- or
extra-cellular accumulation. Although much less is understood with regard to their
function and the pathophysiological role of their misfolded conformers, a profusion
of descriptive data on palpably or potentially involved proteins has accumulated
and has revolutionized our knowledge on these disorders and on the protein folding
problem. α-synuclein, β-amyloid, prion protein, among many others, are all neu-
rodegenerative disease-related proteins that fall in the increasingly wide category
of “Intrinsically Disordered Proteins” (IDPs). The observation that totally or par-
tially IDPs function stems from the their natively unfolded state, in other word,
from their lack of a well-defined three dimensional (3D) structure in physiological
conditions, remodelled the traditional (but limited) paradigm of structure-function
releationship. While proteins involved in structural and enzymatic activities are
—often—distinguished for a stable folded 3D shape, IDPs seems to took advantage
of their native disorder to perform regulatory, and therefore versatile, functions.
Prion disorders are invariable lethal neurodegenerative maladies that can manifest
themselves in all three forms of genetic, infectious and sporadic disease. Moreover,
prion diseases are probably the neurodegenerative diseases for which the largest
amount of data have been collected for both humans and animals (1). Prion dis-
eases include bovine spongiform encephalopathy (BSE) of cattle, scrapie of sheep,
chronic wasting disease of deer, moose and elk (CWD), and Creutzfeldt-Jakob dis-
ease (CJD), familial fatal insomnia (FFI) and Gerstmann, Straussler and Scheinker
(GSS) of humans.
The prion, PrPSc,1 consists of a conformationally altered isoform of the prion pro-
tein (PrP), a normal, membrane-anchored host protein, designated as PrPC . Prion
replication seems 2 to involve the direct interaction between a pathogenic PrPSc
template and the endogenous cellular PrPC . This interaction has been proposed
1The abbreviation “Sc” means Scrapie, the term that designated the prion disease in sheep,
the first animal in which it was observed as a compulsive twitch to scratch themselves.
2The intervention of a possible Protein X to mediate the interaction, the misfolding, the ag-
gregation cannot be excluded
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to drive the formation of nascent infectious prions (2). PrPC is necessary for prion
replication and for prion-induced neurodegeneration, yet the proximal causes of neu-
ronal injury and death are still poorly understood. This is one the most intriguing
and peculiar characteristic of prion diseases, their ability to propagate themselves
by imposing their conformation onto the cellular prion protein of the host. And the
second intriguing aspect, is that the host may be not only another cell of the same
organism (like in sporadic and genetic diseases), but also of another organism of
the same specie (let’s think at the Kuru disease transmitted through cannibalistic
rituals) or from another one, as it became terribly worrisome during the widespread
of BSE when the transmission to human via meet consumption was assessed (the
vCJD). Great concern arised in the scientific community when the transmission of
vCJD through blood transfusion to a recipient patient was ascertained, as current
detection technique are unable to detect PrPSc at the suspected infectious concen-
tration in blood.
To date, no effective ante-mortem diagnostics for prion diseases have been devel-
oped, as, among the difficulties, the infectious concentration is expected to be lower
than fM in blood (3, 4, 5), below the detection limit of standard techniques like
ELISA and Western Blot (6). From the above it follows that prion studies would
clearly benefit from the existence of a low protein consumption nanoscale assay,
such as the one presented here. Potential fields of application are in vitro studies
investigating interactions and/or related morphological changes of PrP in native like
(or physiological) conditions.
This work aim at determining the optimal nanostructure design for an Atomic
Force Microscopy-based, immunoassay-like device for the oriented immbolization of
recombinant mouse prion protein (residues 89-230). Recombinant (rec) mouse (Mo)
PrP has been largely investigated in cellular systems and structural studies (7, 8).
The discovery that recMoPrP residue 89 to 230 (hereafter recMoPrP(89-230)) can
produce infectious prions when polymerized into amyloid fibrils in vitro has opened
many new avenues of research (9) because it provides a platform for the study of
prion replication in vitro. Nevertheless, much work remains to be carried out to-
wards the identification of more efficient in vitro conversion protocols. Molecules
binding to either PrP conformers may interrupt prion production by inhibiting this
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interaction. Additionally, compounds that bind to supporting molecules that par-
ticipate in prion production, such as chaperones or other ligands, may also be good
candidates for blocking the fibril formation.
To our knowledge, very little attention has been devoted so far to the charac-
terization of surface nanostructures of prions immobilized in a controlled orienta-
tion. On one hand, fibrillar growth has been characterized by AFM, but with little
control over the orientation of the monomeric prions (10, 11). Surface based as-
says like ELISA or Biacore, on the other hand, have converged towards analytical
devices able to study biorecognition phenomena, but without a the potential sensi-
tivity that nanoscale control of the surface functionalization implies. Atomic force
microscopy precise interfacial nanostructure measurements allows for the characteri-
zation of the antigen-antibody biorecognition phenomena on the nanostructure with
unprecedented control over PrP orientation.
The achievements in prion protein oriented immobilization at the nanoscale will be
preceded first by an overview of protein immobilization strategies with a particular
attention to the challenges posed by nanosized structuring of interfaces. Then, an
introduction to the Atomic Force Microscopy as an imaging and a nanopatternig
tool will follow, in which key concepts will be depticted that are instrumental to the
description of the experimental set up and the interpretation of the results.
.
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2Proteins at Nanostructured
Interfaces
The extreme adaptation potential of living organisms is achieved by a finally
tuned and regulated expression, in time and space, of the genome, so that system
homeostasis is mantained and adapted in a concerted connection with the external
environment. Protein expression is regulated right from gene activation, transcrip-
tion, splicing, and translation, to folding, post translational modification (PTMs),
degradation and disposal. Human genome contains 23000 genes, a considerable
fraction of which –40÷60%– gives alternative splicing isoforms after transcription.
To this sequence-information variability, roughly 200 different types of PTMs add
additional chemical diversity, so that ∼106 different proteins are expressed in a cell
with abundances that span several orders of magnitude (12). The relative changes
in specific protein content and their modifications is a signature of the cell state
and therefore it is much more informative on the ongoing cellular, and eventu-
ally systemic, processes: this is the reason that boosted proteomic applications to
biomarker’s discovery and detection, initially for cancer(13, 14, 15), and now as a
general approach to early diagnosis and personalized medicine (16, 17).
Since their introduction in 1995 (18), protein microarrays offered a route for sys-
tematic and high throughput investigation of dynamic proteome expression down to
the single cell level(19, 20, 21), protein-protein interactions, protein-ligand interac-
tion, drug screening (22) and, last but not least, novel opportunities in diagnostics
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with fast, sensitive protein detection(23, 24). The requirement to monitor tiny
amounts of proteins within the smallest possible detection volumes for research and
diagnostics is the main driving force for the development of novel protein detec-
tion devices. Ultrasensitive measurements of proteins can be achieved “naturally”
through miniaturization by nano-patterning (25, 26). Beyond high sensitivity, minia-
turization also allows for parallelization, multiplexing and eventually high through-
put detection schemes(6, 27, 28). Above all, however, miniaturization implies short
diffusion times (that at high dilution are essential) and low sample consumption
without a corresponding loss of signal-to-noise (S/N) ratio. On the other hand,
regardless of the sophistication of the sensor fabrication or signal readout, the de-
tection limits of micro- and nano-scale solid-phase arrays for protein analytes still
remain well above the expected performances, which are in the attoM (10−18M) and
zeptoM (10−21M) range (29, 30, 31).
Concerning sensitivity, current state of the art is in the low pM to fM range
(6, 32). This is in contrast with the very high performance of DNA micro- and nano-
detection methods in which biochemical amplification methods can be used easily
and have pushed sensitivity at a level sufficient for all but the most demanding ap-
plications4, in particular early detection of tiny amount of low abundant biomarkers
like prions, interleukins and hormones (though sophisticated technological improve-
ments on single molecule enzyme-linked immunosorbent assay (ELISA) are now ap-
proaching sub-femtomolar sensitivity (33)). Nanotechnology was expected to have
a much faster penetration in the diagnostics market than it actually had, since all
nanoscale driven approaches to protein interaction studies are still packed in the
"proof-of-principle" box. Probably, more than disobeying the "ten times cheaper,
ten times better" rule of this market, the intricate mixture of sophisticated technolo-
gies and advanced competence required to operate these new procedures limited the
pervasive breakthrough in biomedical sciences. Personnel indeed must be provided
with proper expertise and interpretative tools for the huge and new amount of data
accessible through nanotechnological application to the clinical practitioner.
So far, the accepted gold standard for single-protein measurement is immunoas-
say, which exploits the diversity and specificity of antigen binding by antibodies
or aptamers, with the biorecognition process being governed by thermodynamic
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equilibrium and suffering from time scale limitations. This becomes obvious in the
typically diffusion limited reaction kinetics that may prevent the interaction to hap-
pen in practically reasonable time scales, especially at low concentrations (< fM
range) (32, 34, 35).
As a consequence, an improved understanding of the physicochemical character-
istics of the recognition process and the properties of nanoscale protein detection
devices is necessary to push and optimize their performance, particularly for the
recognition and immobilization of intrinsically disordered proteins. Their folding
and stability, in fact, might be easily influenced by environmental factors and the
effect of local confinement.
This chapter will review briefly advantages and disadvantages of common pro-
tein immobilization chemistry, protein confinement at addressable location for mi-
croarray fabrication, and the advantages of the use of AFM both for biomolecules
nanopatterning and for detection of binding events on the surface. Atomic Force
Microscopy (AFM) which will be discussed throughly in the next chapter, have suc-
cessfully demonstrated patterning of molecules, including stable protein structures,
with sub-micrometric resolution. Moreover, the intrinsic versatility of AFM for
surface biochemical studies, provides a comprehensive tool for controlled nanofabri-
cation and subsequent investigation of the interactions between the molecules and
with the interface via both height measurements and lateral deflection (e.g. molec-
ular friction) with respect to a very flat reference substrate.
2.1 The Advantage of Measuring Protein Protein
Interaction at Interfaces
Solid phases have been introduced in biomolecular interaction studies with an-
alytical purposes almost half a century ago ((36), and see for example one early
application of ELISA in human choriogonadotropin detection (37)). However, their
potential in fundamental studies has been time to time re-dimensioned by an under-
lying skepticism about the capability of bound molecule to behave as if they were
in a native environment or even to mantain their intact functionalities. In living
9
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organism, binding events occur both in solution and at interfaces (i.e. on the cell
membranes). Enzymatic reaction in the crowded cytoplasm, or in blood, and non-
self antigen recognition by circulating antibodies are an example of the former case,
while signal transduction events (that involves virtually all membrane bound recep-
tor - ligand interactions), and antigen presentation by the major histocompatibility
complex (MHC) are some well studied cases of the latter.
The investigation of biorecognition phenomena, the characterization of binding
properties, or the use of biomolecular binding as the mean for concentration de-
termination or analyte detection, all can then be performed in bulk or interfacial
environment. Although reconstructing a platform mimicking the native landscape,
in terms of environment and geometry, in which the biomolecules are usually playing
their role appears to be the better choice, it is not always an easy and straightfor-
ward task, and, depending on the application field of the test, it might not be the
best assay design.
Solution studies of binding parameters benefit of an isotropic distribution of
the binding partners, whose diffusion constants (translational and rotational) are
well-studied, a thermodynamically equilibrated boundary conditions, and an homo-
geneous micro-environments of binding sites, that is of special importance when
nanoscale assay are involved . The major drawbacks of the traditional bulk solution
approach are, beside the volumes and sample quantity involved, the difficulties in
separating the bound and unbound species to quantify the actual amount of bound
probes, and the lack of in situ monitoring of reaction kinetic rates.
Picturing the binding process, indeed, requires the accurate determination of
the amount of either the free or the bound ligand, provided that a sensitive labeling
technique for one of the partner is available (i.e. radioactive or fluorescent labeling)
to probe the interaction, and a suitable separation technique is employed. Labeling
entails separation, since the signal coming from the label is associated —generally—
with the only presence of the molecule, and not with its bound or free state. Some
common separation practices uses gel filtration, ultracentrifugation, ultrafiltration,
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or equilibrium dialysis among others (38). The choice of the separation method re-
lies upon kinetic consideration (or eventually raw estimation) on the mechanicistic
events of binding. In particular, the lab process used to separate the bound and free
state has to be fast compared to the reaction dissociation rate constant, otherwise,
when the time scale are comparable, the equilibrium is disturbed by separation of
the reactants.
The introduction of heterogeneous phase assays, in which one of the part-
ners, the receptor, is linked to a sensor surface, was initially a mean for the easy
spatial separation of the bound from the unbound phase in solution. Moreover, a
solid substrate provides easy-handling, portability, parallelization and multiplexing.
Likewise, the use of a planar substrate (in opposition to micro and nanoparticles
or microporous materials) allows for the implementation of surface sensitive tech-
niques, that can even overcome the tedious (and sometimes denaturing) practice
of molecule’s labeling for detection purposes, but, more intriguing, it allows for in
situ monitoring of binding events on the surface, without any interference from the
unbound molecules in the surrounding solutions.
One characteristic that distinguishes nanoscale structures from macroscopic ma-
terials is that they presents a high percentage of their constituent atoms at a surface.
(The volume of an object (V ∝ l3, where l is the characteristic length) decreases
more quickly than its surface area (S ∝ l2) as the size diminishes: S/V ∝ l−1, where
l has atomic or molecular dimensions). This scaling behaviour leads, in the most
extreme case, to structures where nearly every atom is interfacial and experience a
different environment from those in the bulk (israechv,whitesides,Phillips): different
free energies, electronic states, reactivities, mobilities, and structure. Ipso facto,
interface is where gradients in properties are greatest, and so is the possibility to
characterize those properties. This is both the blessing and the curse of employing
nanostructured interfaces for biomolecules’ interactions studies. The surface itself
can be thought of as a label in the broader sense of it. Surface deposition aims at
confining the molecule in an interfacial environment where it may be opportunely
stabilized in time and space, and where small variation due to alternative state of
the molecule immobilized —a reflection of protein activity— are enhanced and de-
tected by surface sensitive technique. However, in common practice, the term label
11
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is operationally defined as the attachment of a fluorescent, radioactive, enzymatic
moiety that act as a reporter probe.
Immobilizing molecules on a surface enables local enrichment of the receptor with
minimum sample consumption, though the high local density could actually trigger
non negligible concentrations gradient of the ligand in solution, and be influenced by
the binding state of the neighbouring receptors and the surrounding environment.
Even when non affecting protein functionalities, the immobilization procedure itself
renders the binding process mechanistically anisotropic, and, in addition, the surface
may interact as a non specific binding (NSB) substrate.
2.2 Nanoscale molecular recognition interfaces
The proper surface material and surface functionalization chemistry are chosen
for fabrication depending on the nature of the biological receptor, the detection
methodology, and ultimately on the application for which the device is meant. Once
a suitable receptor, which provides the specificity and affinity for the target analyte,
is identified, the design of the molecular recognition interface involves the attach-
ment of that receptor on a surface, and preferably its confinement to an addressable
location. This linkage has to be selective enough to favour the proper orientation
of the functional binding cleft, the distribution homogeneity and the degree of free-
dom of the tethered molecules, their lateral isotropy that turns into equality and
accessibility of binding sites, and the minimization of non specific binding.
2.2.1 A Gold Standard For Planar Surfaces
Exploitation of interfacial phenomena for binding studies requires careful design of
the sensor device. Among different and widely characterized possibilities, we chose
ultraflat gold substrates opportunely functionalized via specific thiol/Au interac-
tion to accomodate proteins at precise location in controlled orientation. Both the
fabrication and detection steps were accomplished with the use of Atomic Force Mi-
croscopy, a scanning probe technique that can image local properties of surfaces with
high spatial resolution even in liquid environment, through the control of proximity
atomic interaction between a sharp probe and the surface features.
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At the nanoscale, the roughness of the surface is of comparable size to the object
to be studied, and might create multiple micro-environments in which the receptors
and therefore the binding sites are distributed: this will affect the determination of
binding parameters, since multiple binding events will take place at the same time,
and an average of multiple effective binding constant will be ultimately recorded.
Thus, the preparation of the gold planar surface is of utmost importance. Gold can
be easily evaporated onto different substrates and grown to a polycristalline layer
presenting atomically flat terraces (also referred to as Au (111) surfaces). However,
for the purposes of nanosensor devices, these terraces are of too small area (below a
few hundreds nanometer square), and the global roughness, expressed as root mean
square deviation, may reange between 3 and 10 nm (39). Gold surfaces presenting
low roughness on larger scale are produced using the Template-Stripped Gold (TSG)
procedure (40) or its modified protocol by Ulman (41). Gold is evaporated on atom-
ically flat mica, and then mechanically (or solvent) separated from it by using a flat
hard surface strongly attached to the gold layer (usually, a resist is used). In this
way the gold film attached to it exposes the gold surface originally buried at the
interface, reproducing the flatness of mica, giving an extremely reduced roughness
of about 4 Å. This is the substrated used in this thesis for the fabrication of nanos-
tructured interfaces.
Widespread adoption of thiolate monolayer growth on gold thin films arises from
the inhert nature of gold, its ample compatibility with multiple transducer technol-
ogy (electrochemistry, synchrotron radiation based techniques, SPR (Surface Plas-
mon Resonance), AFM...), its biocompatibility, and, of course, from the well-known
mechanism of spontaneous self assembly of thiols. Self assembly subsumes the spon-
taneous formation of complex hierarchical structures from pre-designed building
blocks, typically involving multiple energy scales and multiple degrees of freedom,
a peculiarity exploited and evolved by living organisms. Specifically, self-assembled
monolayers are ordered molecular assemblies that are formed spontaneously by the
adsorption of a surfactant with a specific affinity of its tail to a substrate, that,
though often thought as planar, may be of different geometries. Since the discovery
of the thiol-Au specific route by Nuzzo et al (42), an enormous variety of chemically
diverse thiolated molecules have been self assembled on gold —and other metal—
substrates, with extensive and detailed structural analysis of the hierarchical packed
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structure of these thin films (39, 43). In addition, thiols are conveniently prepared
by submerging a gold surface in a solution containing the thiol of chosen headgroup
functionalization.
SAM of thiolated molecules are also a convenient way of sensor surface pas-
sivation preventing non specific protein adsorbtion out of the localized area for
functionalization (44, 45). Oligoethyleneglycole (EG, three to six residues) termi-
nated thiols are well known to protect from unspecific adsorption of biomolecules
on surface. This "bioresistant" properties is common to other polymer brushes, in
which flexible uncharged moieties are enriched in hydroxy groups, that, in aqueous
solutions, become highly hydrated, are not ionizable under physiological conditions
and protect from hydrophobic-driven denaturation (38). The exact reason for the
protein resistance of EG has been subject to some debate, but it is now accepted
that it is mainly due to the unusual interactions with water molecules afforded by
the EG chains, creating an energetically favorable water structure which is not easily
interrupted by proteins (45). In addition, steric effects and the lack of a net elec-
trostatic charge are also likely to contribute to the protein resistance of EG-based
materials.
An enormous variety of derivatized thiols are available for subsequent surface
chemistry, like protein functionalization. The way this functional group is intro-
duced in the SAM range from presenting a mixed solution to the gold, to micro- and
nano-patterning of the desired molecule, and will be reviewed in a following section.
2.2.2 Protein Immobilization Techniques
Protein immobilization at the micro and nanoscale has evolved in the latest years
from simple and less effective physical adsorption to sophisticate combination of non
covalent and covalent chemistries.
2.2.2.1 Physical adsorption of proteins
Protein physisorbtion relies on non-selective ionic, van der Waals, electrostatic
and hydrophobic interactions of the protein molecules with the hosting surface. The
strength of the interactions may be enough to stabilise the immobilization of the
proteins on the surface, that, however, lie in an unhomogeneous and uncontrolled
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orientation, and are prone to time-dependent, slow thermodynamically-driven un-
folding (due to the spontaneous tendency to increase the amount of hydrophobic
contact between the polypeptide and the surface and minimize the interfacial inter-
action energy).
This non selective hydrophobic or electrostatic driven interaction between polypep-
tides and surfaces is actually the basis also for non specific —and therefore, undesired—
adsorption of proteins to biochips and, in general, to biocompatible micro- and
nano-structured materials, and is of great interests for prosthetic material and drug
delivery optimization. Effects like the protein corona, that is the decoration of
nanoparticles with endogenous proteins as they circulate in the bloodstream, or un-
specific background in microwell and microarray test modify their performances.
2.2.2.2 Covalent immobilization of target molecules
Covalent linking of proteins offers the enormous advantage of a very sta-
ble functionalized surface over time. Proper functional moieties are located on the
surface to react with, possibly a few, residues of the protein to be immobilized.
Chemistries which allow direct coupling to amino acid residues are generally pre-
ferred due to their universal applicability. The mostly used examples are depicted in
figure 2.1 and include N-hydroxysuccinimide (NHS), imidazole carbamate, epoxide
and aldehyde groups, which may react with lysine residues, and various thiol-reactive
chemistries, which may react with free cysteine residues. Antibody immobilization
benefit also of chemistry targeting post translational modifications like the glycosi-
lation moieties, or disulfide bridgs.
It is very common to exploit the reactivity of activated carboxylic groups towards
free amino groups, since it is a highly generalizable procedure and works easily both
on purified and recombinant proteins (which may lack organism specific PTMs).
Carboxylic groups can be patterned onto the surface, and then activated through
carbodiimide and NHS to react with  amino groups in lysine side chains, as it will
be also shown in chapter 4 for an alternative recMoPrP immobilization strategy.
Standard covalent cross-linking strategies does not usually provide any selective
reactivity. Therefore, the resulting protein layer is heterogeneous in orientation and
15
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Figure 2.1: Common covalent chemistries for protein immobilization - a)
Water-soluble EDC-mediated activation of a carboxylic group on the support.
The resultant reactive NHS ester can then be coupled directly with available amino
moieties of a receptor (R) to form a stable amide linkage. Alternatively, subse-
quent activation steps allows for a variety of other coupling. Derivatization with
sulphydryl-reactive reagents (PDEA or SPDP) allows reaction with free surface thi-
ols (for example, cysteine or methionine). Stable thioether bonds can be formed
using maleimide coupling reagents, such as sulpho-SMCC and GMBS. The surface
can also be derivatized with cystamine to effect coupling with disulphide-activated
proteins. Finally, treatment with hydrazine followed by a reductive amination al-
lows coupling with aldheydes. b) Amino-presenting surfaces can be treated with
bifunctional linking reagents for coupling with free amino or sulphydryl groups on
the protein. Adapted from (46)
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function, and is likely to have an heterogeneous response to any stimulus applied,
including an heterogeneous binding behaviour, decreasing the overall performances
of the device.
Recent applications of site specific covalent immobilization like Staudinger lig-
ation, click-chemistry, copper free click chemistry, and derived protocol suitable
to non denaturing protein immobilization, all step forward for reliable orientation-
selective linking. However, many of these protocols involve the reaction of the func-
tional moieties on the surface with an activated protein, that is, a protein chemically
functionalized with a suitable reactive linker. Some of this linker can be genetically
encoded in few cases in recombinant protein (i.e. tioesther groups). This protocol
requires some expertise, and up to know much of the applications are relative to
model synthetic peptides and very rarely to native proteins 1.
A straightforward and convenient route for direct, site specific immobilization
of proteins and peptides takes advantage of the specific reaction between cysteine
thiols and gold. As it will be shown in chapter 3 (section 3.3.2), protein can be
engineered with a double cysteine tag (Cys2-tag) in known position (either the
N-terminal or C-terminal side), allowing for site specific covalent linking. The only
drawback of this approach, compared to other fusion peptide described later on,
is that in some cases folding might be affected. In fact, proteins which folding is
stabilized by disulfide bridges between native cystein residues may form non native
disulfide bonds with the additional cysteines of the cys-tag.
2.2.2.3 Biochemical affinity immobilization
Bioaffinity non covalent immobilization (49, 50) exploits the specificity and the
affinity of biomolecules for some particular ligands, and provides not only oriented
and homogeneous attachment but also the possibility of detaching the protein and
thus repeated use of the same surface. The kind of biochemical affinity used involves
antibody antigen interactions, immobilized metal affinity, substrate-receptor affin-
ity. Many protein can be recombinantly engineered with a proper tag that brings
the suitable affinity interaction for oriented immobilization. Concerning antibody
1Recent and detailed overview o these novel chemistries and their application can be found in
(47, 48)
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immobilization, they can be used to orient their antigen on the surface, provided
their binding site is oriented too.
• Avidin-biotin based systems make use of the strongest noncovalent known
binding affinity between streptavidn and biotin (Kd = 10−15M). Biotin label-
ing of molecules (which can be achieved through reaction with maleimido or
carboxylic activated groups) ensures a tight and stable surface derivatization.
• Protein A immobilization is based on the high affinity and binding speci-
ficity of Protein A, a surface protein of Staphylococcus aureus, towards the Fc
region of a broad range of mammalian immunoglobulins (Ig). Protein A layer
are immobilized, via affinity capture, physical adsorption or covalent coupling
to a surface, and then the IgG layer is captured in an oriented manner.
• Fusion proteins are engineered to encode in one polypeptide chain the pro-
tein of interest and a fusion tag, used for chemical linking to the surface via
affinity for a specific substrate (38). Many of this fusion system have been ex-
tensively studied for protein purification purposes. Glutathione S-Transferase
(GST) binds to surface-immobilized glutathione, Maltose Binding Protein
(MBP) binds to surface-immobilized maltose or maltotriose, FLAG R©peptide
is recognized by a specific antibody, the enzyme O-6-alkylguanine-DNA alkyl-
transferase (known as SNAP-tag) binds to benzylguanine. The major draw-
backs of all of them is the bulky steric hindrance that this fusion tag exert on
the proteins, sometimes affecting their folding, stability, and activity.
• Semisynthetic DNA-protein conjugates, like DNA-Directed Immobiliza-
tion (DDI) (51) of proteins, merge the high specificity of Watson-Crick base
pair DNA recombination with the dynamic potential of protein interaction.
Semi-syntheic ssDNA-Protein conjugates have been developed (51) and found
extensive applications for self assembled protein layers. DNAmicro and nanopat-
terning through self assembling was boosted for DNA microarray application
in genomic and transcriptomic studies, and stable dense parrallel DNA mi-
cro and nanoarray can be produced routinely. Eventually, the use of different
complementary ssDNA oligos tagged with different proteins of interest easily
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transform a DNA micro array into a protein array, where the DNA sequence
provides the address for the protein molecule on the surface.
• Poly-histidine tags, or His-tag, of 6 to 10 histidine residues (52, 53), was
a fusion protein method originally developed for affinity chromatography of
histidine-rich proteins. These are the most versatile example of fused pep-
tides, so they merit a separate description. His-tag is of tiny dimension, rarely
affect the folding and stability of the target protein since rarely produces de-
structive interaction with the fused polypeptide chain, and has a very low
immunogenicity, so it doesn’t —generally— affect antibody production from
the recombinant protein.
Figure 2.2: NTA-Ni(II)-His-tag Immobilization Strategy - Histidine coordination of
a Ni (II) atom trapped on a surface is shown. Adapted from (46)
Complexation of histidine residues with immobilized transition metal ions of-
fers powerful solutions. Transition metal ions such as Zn(II), Cu(II), Ni(II) in
particular, or Co(II) are immobilized by chelating agents such nitrilotriacetic
acid (NTA), thus maintaining 2 coordination sites free for histidines. This in-
teraction can be very efficiently disrupted by competing coordinators such as
imidazole, which selectively and rapidly remove the protein from the surface
under mild conditions. Two are the major drawbacks: the long-term stabil-
ity of the derivatized surface, that depends in primis on the density of NTA
groups on the surface (53, 54), and the lack of simultaneous multiplexed func-
tionalization, that is, each NTA group will react with whichever his-tagged
protein is in the surrounding, so multiple proteins immobilization has to be
achieved, if at all is possible, only in a sequential, non parallel, protocol, or
has to be coupled with nanoscale dispensing of each protein that has to be
immobilized.
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Both DDI and NTA-Ni-His-tag system have been used in self assembled mono-
layer on gold and patterned with a variety of technique involving soft lithography
and µCP as well as scanning probe lithographic technique like DPN and NG. Next
chapters will review in much more details the achievements of the combination of
these surface chemistry with AFM-based nanopatterning.
2.2.3 Nanostructuring the interface
Traditional microfabrication technologies like soft-lithographic techniques, micro-
contact printing (µCP), nanoimprint lithography (NIL), nanosphere lithography
(NSL), electron beam lithography (EBL), focused ion-beam lithography (FIBL)
are able to provide micro and nanostructured interfaces on which protein can be
subsequently accomodated, either by physisorbtion, or secondarily to one of the
many chemical surface functionalization already described1. Protein microarray
were firstly fabricated with the use of an ink-jet printer based instrument, in which
the ink was substituted by the protein solution. In spite of the high resolution
nanofabrication techniques introduced, like EBL, FIBL, the concept remains very
much similar: either the protein or a suitable chemical linker for it has be specif-
ically confined to a target area. However, in addition to non nengligible costs of
these equipments, and to the exquisite expertise required to operate them, two ma-
jor issues still are not properly solved: compatibility with protein printing reagents
and functionalization of the individual features with different proteins without com-
promising the entire surface.
Nanodispensing provides a mean for local delivery of the receptor molecule to
its spot on the array with nanosized pipette; conductive atomic force microscopy
(c-AFM)(56), dip-pen nanolithography (57, 58, 59), native protein nanolithography
(60) as well as nanografting (61, 62, 63, 64, 65, 66, 67), have been successfully used
for fabricating arrays of proteins with submicrometre resolution in native-like con-
ditions. The advantage of Atomic Force Microscopy based lithographic technique
will be addressed in details in the next chapter. The extraordinary versatility of
this technique, that encompasses nanolithography, high resolution morphological
1Recent applications on protein immobilization have been extensively reviewed elsewhere. See
for example (6, 44, 55)
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studies, direct detection via interfacial proterties (simple topography, or molecular
friction) of events taking place on surfaces, the possibility of coupling with electrical,
electrochemical or optical detection methods, makes AFM the election methodology
for in situ accurate investigation of biorecognition phenomena.
2.3 A small appendix on the sensitivity of nanos-
tructured device
Characterization of binding events implies a carefully design of the assay that be-
comes crucial when nanostructured interfaces are used to present one of the binding
partner.
2.3.1 A reminder for quantitative binding analysis
The biorecognition process between two interacting partner, a receptor1 R and
its ligand L can be described as a function of their concentrations:
[R] + [L]
kon
koff
[RL] (2.1)
where kon and koff are, respectively, the association rate constant (in units of
M−1min−1) and the dissociation rate constant (in units of min−1).
Binding occurs when ligand and receptor collide due to diffusion with the proper
collision energy and orientation; the association rate, that is, the number of binding
events per unit of time is expressed as:
v(t)association = [R] · [L] · kon (2.2)
Once binding has occurred, the ligand and receptor remain bound together for a
random amount of time. The probability of dissociation is the same at every instant
of time, i.e. it doesn’t depend on the actual duration of the interaction. The rate
of dissociation is:
v(t)dissociation = [RL] · koff (2.3)
1The term receptor is used here in a wider sense: it represents the protein in limiting and
fixed amount in the assay, and usually —but not always— is the one immobilized in heterogeneous
phase assays
21
2. PROTEINS AT NANOSTRUCTURED INTERFACES
At thermodynamic equilibrium, the forward and backward reaction’s rate will bal-
ance each other, so that the net variation of the reactants and products is zero.
kon[R] · [L] = koff · [RL] (2.4)
The law of mass action relates the relative concentration of the actors involved to
the affinity constant:
Kd =
koff
kon
(2.5)
The thermodynamic equilibrium constant, also called affinity or dissociation con-
stant Kd, is a global descriptor of the binding behaviour at equilibrium condition,
although only the knowledge of kon and koff may give insights on the molecular
mechanism. The dimension of Kd is expressed in concentration units (M), and it
point to the simplest interpretation of its meaning: at concentration of ligand L
equal to Kd, the conentration of free receptor R equals the concentration of lig-
and bound receptor RL, that is, Kd equals the concentration of ligand necessary to
achieve saturation of half of the receptor present in solution. It gives a measure of
the affinity of the ligand for the receptor. The quantitative analysis of Kd, whether
in solution or on surfaces, of protein-protein interaction governed by the law of mass
action relies on the following specific assumptions:
• Interaction is reversible. In the simplest case, association is a bimolecular
reaction, while dissociation is a unimolecular rection.
• All receptor molecules are equivalent and independent.
• Components do not undergo any chemical reaction and exist only in bound or
free state.
• Interactions are measured at equilibrium.
• The measured response is proportional to the number of occupied receptor
sites.
Provided that these assumptions are satisfied, the simple model of the law of mass
action predicts the fractional receptor occupancy (the amount of receptors bound to
ligand) at equilibrium as a function of ligand concentration. From an experimental
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point of view, the relationship (at equilibrium) between ligand concentration and
Kd has then to be re-arranged, and expressed in the form of free (f ) or total (t)
ligand and receptor concentrations:
Kd =
[Rf ][Lf ]
[RL]
(2.6)
then, considering that:
[Lf ] = [Lt]− [RL] (2.7)
and that:
[Rf ] = [Rt]− [RL] (2.8)
the fractional occupancy, or fractional saturation of the receptor is:
[RL]
[Rt]
=
[Lf ]
Kd + [Lf ]
. (2.9)
Rarely surface-based assay can measure easily the amount of free ligand. Most of the
experimental techniques, including the very sensitive ones, monitor binding through
the evaluation of saturation of the receptors, with the underlying assumption that
the signal retrieved is directly proportional to the amount of complex RL present at
equilibrium. It is therefore useful to rearrange the relationship between bound and
free ligand as follow:
[RL] =
[Rt] + [Lf ]
Kd + [Lf ]
(2.10)
Unfortunately, most of the solid-surface experimental set up cannot afford at all
the measurement of Lf . However, on the assumption that the depletion of ligand
operated by the tiny amount of receptor immobilized on miniaturized devices is
negligible, and since the Lt is the known variable, usually an approximate value of
Lf ∼ Lt is used1:
S[RL] =
Smax + [L]
Kd + [L]
(2.12)
1Actually, if Lf is not explicitly measured an appropriate solution of the binding equation to
obtain Kd requires that the quadratic equation relating fractional occupancy to Lt is solved:
[RL]
[Rt]
=
([Rt] + [Lt] +Kd)−
√
([Rt]− [Lt]−Kd)2 − 4[Lt][Rt]
2[Rt]
(2.11)
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where S[RL] is the measured signal proportional to bound ligand at a given [L], and
Smax is the measured signal at receptor saturation. In such a form, the dependence
of [RL] as a function of [L] can be easily fitted to a rectangular hyperbola in order
to derive Kd.
It is frequent to express the dependence of [RL] on the logarithm of ligand con-
centration, so to obtain a sigmoidal dose-response curve of adsorption, which can
expressed in varoius form, like:
S[RL] = SL=0
SL=max − SL=0
1 + 10LogKd−[L]
(2.13)
2.3.2 Law of mass action and nanostructures.
When the experimental set-up involves the use of a surface, the previous de-
scription can apply only to idealized experiment in which the binding sites can be
considered independent and freely accessible from the ligand partner (as it was al-
ready mentioned), and the concentration of the molecules on the surface should low
enough that the binding reaction does not lead to significant depletion of the ligand
molecules in the nearby solution, hence no concentration gradients is present, that
is equivalent to assuming that the ligand has an infinitely fast diffusion constant.
This is also known as “rapid mixing model” (31, 32, 34, 35, 38, 68). However, to
enhance sensitivity, high density layer of immobilized probes are used, and some
rough estimations on the possible performances of the device might prove useful. If
a concentration gradient is present, the system become diffusion limited, and the
performances of the device may be reduced, in terms of estimation of detection lim-
its and Kd.
Introducing nano-scale device often increases the signal-to-noise ratio (S/N), an
inherent advantage for signal transduction that would suggest a concomitant in-
crease in the chances to detect very low amount of target analyte. However, if the
target analyte is very diluted, the local concentration of capturing probes on the sur-
face could be —in proportion— so high to deplete the analyte from the surrounding
solution. Mass transport limitation, in this case, should be taken into account.
According to Sheean et al. [(35)] smaller patch size enhances the establishment
of mass transport limits in the system. The authors examin theoretically the phe-
nomenon, and suggest that reported femtomolar detection limits for bioassays are
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likely to be an analyte transport limitation, not a signal transduction limitation.
The consequence is that, without methods to actively direct biomolecules to a sen-
sor, the nanodevice surface requires too much time to saturate with the target the
functionalized patch at low concentration1. It has been reported (34) that for yes/no
determination of target mass transport limit is not an issue, since device stability
can reduce the incubation time to the minimum time required to immobilized the
minimum numbers of molecules sufficient to give a detectable signal. However, quan-
tification and binding characterization, that is our main concern, still depends on
the average equilibration time. It has been widely examined (29, 31, 32, 69) that
analyte preconcentration or active method (i.e. electrochemical gradients, magnetic
nanoparticle driven concentration) to directly target the analyte on the spot are of
moderate help if the physicochemical properties of the nanostructured interface are
not well optimized.
The incubation time, for example, that is the time the system is allowed to reach
equilibrium, needs to be chosen accordingly to the ligand receptor pair of the system.
Let’s take as a practical example recMoPrP(89-239) and either D18 or CloneP, the
two recombinant, histidine tagged fragment of antibody that we used to selectively
orient the prion protein on nanostructures, as it will be shown in Chapter 4. The
incubation time was estimated from the kinetic parameters evaluated by Safar et
al.[(70)] via Biacore experiment for the two antibody employed in our study: the av-
erage mean time 1
koff
of the complex is supposed to range between half and 19 hours,
while the average lifetime (ln2/koff ) spans accordingly between half and 13 hours.
However, considering the report of Kusnezow and coworkers [(32)], we may estimate
in ideal condition (absence of mass transport phenomena and steric hindrance of
binding site) that the ideal time as a function of target concentration 1
koff+kon·[target]
for signal “development”, that is the approaching of the thermodynamic equilibrium,
is shorter: from 4 second at a recMoPrP concentration of 900nM, to 12 minutes at
300 nM, 1 hour at 3nM and 5.6 hours at 95 pM concentration. In our experiment,
we doubled the theoretical incubation time while performing the experiment to take
into account eventual deviation from ideality (ee Chapter 4).
1Deriving a simple but useful steady state accumulation equation Accumulation(t) = 4D ·
(NA · C0) · t, the average time is estimated to be of tens of hours at fM concentration for a 1 µm2
patch
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Heterogeneous phase microarray are modelled as two compartment model system,(32,
35) since the presence of a solid phase support affect the diffusion constraints of an
ideal bimolecular reaction in solution. If initially the reaction is governed by the
kinetic rate constant of the specific macromolecular pair involved, then it becomes
progressively limited by the diffusion rate of the target analyte from the bulk solu-
tion to the reaction spot. Even in the steady state condition, the prolongation of
the estimation time actually is not dramatic, due to the small patch size compared
to standard microarray systems (31). Assuming the receptor molecule as a square
of 4×4 nm2, and therefore that the density of receptor ρ on a 1x1µm2 patch is
10−11moles · cm−2, and assuming a slow diffusion coefficient for the recMoPrP of
10−10cm2s−1, the Damkoehler number can be roughly estimated (ρ·pi ·R·kon/4Dfor a
circular spot (31)) and used to correct with a proportional factor the ideal time (the
time needed to reach the steady state between the bulk solution and the compart-
ment surrounding our patch, that is in our case negligible). The reaction duration
actually benefit of the small size of the patches we chose to fabricate: they are small
enough not to deplete significantly the target analyte in the reaction site. However,
if higher affinity constant antibodies were used, that would have terribly affected
the performance of the assay: an increase in affinity of 2 orders of magnitude (let’s
say, in the 20 pM range), usually related to an equivalent increase in the off rate
reaction constant, koff , can actually rise the ideal reaction time to more than 60
hours at pM analyte concentration without any stirring or analyte concentration
device. Concerning prion detection, methods like PMCA (protein Misfolding Cyclic
Amplification) or enhanced concentration/precipitation with polyoxometalates will
surely improve the analytical performance of our device.
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3Manipulating and Measuring
Biomolecules with Atomic Force
Microscopy
This chapter will detail how Atomic Force Microscopy is used to fabricate and
characterize nanopatterns of biomolecules. Before that, there we will overview few
fundamental concepts about the Atomic Force Microscope that are instrumental
to the description of nanografting, the AFM-based nanolithographic technique that
allowed us to orient, among others, the prion protein on nano-scaled structures.
3.1 Atomic Force Microscopy
Atomic Force Microscopy (AFM) belongs to the family of scanning probe tech-
niques (SPM) , which rely on mechanically scanning a sharp probe to investigate
surface properties with extreme spatial resolution. After the invention, in 1981 with
Roehrer, of Scanning Tunneling Microscopy (STM), a technique based on the phe-
nomenon of a tunneling current between a metal needle and a conducting sample,
Gerard Binnig had the intuition that surfaces could be imaged by using a force, and
in 1986 Binnig, Quate and Gerber reported the first use of the Atomic Force Mi-
croscopy (71). In particular, this was made possible by attaching a sharp tip probe to
a cantilever, which deflection could be sensed with angstrom resolution. Scanning
probe microscopies can be classified on the basis of the different nature of the probe
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ATOMIC FORCE MICROSCOPY
Figure 3.1: Schematic diagram of Atomic Force Microscopy - Adapted form
“The AFM Almanac”, Agilent Technology.
tip-sample interactions exploited for imaging (electrical, like STM, mechanical, such
as AFM, optical, or a combination of these, like SNOM, Scanning Near-field Optical
Microscopy), nonetheless, all scanning probe techniques share common features:
• A sharp probe tip (usually the tip radius of curvature is about 10 nm for
standard probes) attached to a soft microsized cantilever spring (whose spring
constant varies, depending on the applications, from the tens of pN/nm to a
few tens of nN/nm).
• A way of sensing the cantilever deflection, usually a beam-deflection optical
detection scheme, in which a diode laser beam is reflected from a mirror-like
cantilever; the position of the reflected beam is sensed with a (four element)
position sensitive photodiode.
• A feedback system, that is able to monitor and control the cantilever deflection
associated with the variation of a monitored parameter sensitive to the tip-
sample interaction, parameter that is usually kept constant with reference to
a set value (as schematically depicted in figure 3.1.
• A mechanical scanning system, based on piezoelectric elements, which allows
for accurate relative movement of sample and tip in a raster manner, in the x-y
plane (lateral resolution), and a Z-actuator, composed of piezoelectric material
as well, to act on the vertical relative movement of the tip.
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Atomic Force Microscopy operational modes are usually distinguished on the ba-
sis of the force involved in tip-sample interactions, the time-scales involved in the
interaction (that influences the time the tip is in contact with the surface), and the
proximity of the sample to the probe tip. All modes enables the user to collect
accurate topographic images of substrates with nanometer lateral resolution, and,
depending on the operational mode, additional information on interfacial properties.
3.1.1 Contact Mode - AFM
In Contact Mode (CM) AFM, sometimes referred to as static mode AFM, the tip
is kept in constant contact with the surface, and the interaction is dominated by rel-
ative short range forces. In idealized conditions (e.g. in ultrahigh vacuum) when the
cantilever tip approaches the sample surface, long-range van der Waals forces start
acting upon it (these forces are sensed at the distance of a few tens of angstroms).
Then when the tip gets nearer to the surface (some angstroms) repulsive force starts
predominating. The force exerted on the tip by the surface causes bending of the
cantilever beam. By measuring the cantilever deflection from its equilibrium (non
interacting) position, it is possible to evaluate the tip-surface interactive force (that
is qualitatively described by a Lennard-Jones potential curve).
The signal from the photodiode detector is the (almost) vertical deflection of the
AFM cantilever (deflection signal), measured usually at or near the free end of the
cantilever using a reflected laser beam. The error signal is the difference between
the deflection signal and the AFM feedback system’s setpoint value, and it is used
by the feedback system to keep the interaction with the surface constant (see figure
3.1). In other words, the user choose a minimum interacting force for imaging pur-
poses. As the tip scans the sample, variation in the topographic profiles may cause
this interaction to change: the error signal registered is used as a feedback signal to
drive a z-actuator that either lift up or down the tip relative to the sample, so to
correct a too strong or a too weak (respectively) interaction, with reference to the
set point. In this way, a topographic profile is reconstructed.
CM-AFM enables high lateral resolution —that can achieve in some conditions
atomic and molecular resolution— although tip deterioration, shear stress and sam-
ple damage are common experimental failure encountered in the practice. Measure-
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ments can be performed both in ambient air or in liquid environment, on a variety
of specimen, including those of biological interest. In the latter case, the interaction
force (the set point) is usually kept to a minimum, not above 1 nN, in order to
maintain the integrity of soft biological materials, like DNA or protein deposited on
bare mica, nanopatterned biomolecule, and living cells (72).
3.1.2 Lateral Force Microscopy
Lateral Force Microscopy (LFM) is a derivative imaging technique of CM-AFM
monitor the lateral deflection (cf. vertical deflection in standard contact mode) of
the cantilever while the tip fast scan direction is perpendicular to the AFM can-
tilever’s long axis. As a result, the detector collects also a non negligible lateral
defection signal from the cantilever’s twisting motion as the raster scanning pro-
ceeds. The strength of the lateral deflection signal is related to the friction force
between the sample surface and the tip. This is why LFM is also called Friction
Force Microscopy. However, the friction signal is highly susceptible to topography
variations; geometrical contribution from roughness, or patterns, adds topography
convolution to the lateral signal. In order to separate the variation in friction force
from the geometric contribution, two lateral force signal are recorded (a forward
and backward trace during each round-trip cycle of the raster scan). Then the dif-
ference between the two signal is the net friction force image. Friction signal are
very sensitive to variation in the chemical properties of the sample, that influences
the proximity interactions with the tip, and give additional information on material
properties.
3.1.3 Non Contact Mode - AFM
In Non Contact mode (NC-AFM), the AFM cantilever is driven to oscillate near
its resonance frequency (73). The cantilever is kept away from the sample surface
(within few tens of nanometers) were long range forces (electrostatic, magnetic, at-
tractive van der Waals forces) are predominant and accessible to the operator. The
oscillations are such that the free end of the cantilever and the tip move along a
gently curved trajectory on a plane perpendicular to the XY plane. The amplitude,
the resonance frequency and the phase shift of the oscillation are the monitored
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parameters that are influenced and link the dynamics of a vibrating tip to the tip-
surface interactions.
In Amplitude Modulation (AM) AFM , also known as Intermittent Contact Mode or
Tapping Mode R©, the observable that the feedback system controls is the cantilever’s
oscillation amplitude. The measured amplitude is compared with a setpoint value,
and the difference, the error signal, is the input into the feedback system (as the
error in the deflection was in CM-AFM), the output of which drives the Z-actuator
that controls tip movement. Since the oscillation amplitude is influenced by the long
range forces exerted by the sample on the tip, amplitude as a feedback parameter is
used to reconstruct the topography of the sample surface. Additionally, complemen-
tary information on material properties variations on heterogeneous surfaces could
be mapped by recording the phase shift between the driving force (the input signal
that triggers the cantilever’s oscillation) and the actual tip oscillation.
One of the main advantages of AM-AFM over CM-AFM is that, since the tip
only intermittently touches the sample surface, lateral shear forces that may alter
the tip or rearrange (i.e. damage) the sample surface during scanning are signifi-
cantly reduced. Despite the difficulties of operating AM-AFM in liquid environment
(where oscillation frequencies are dumped significantly by the viscosity of the aque-
ous medium), it has been successfully applied to high resolution imaging of model
membranes, membrane proteins, DNA-protein complexes, amyloid fibrils (11), pro-
tein nanopatterns and living cells, like neurons (74).
3.2 Nanopatterning Biomolecules with Atomic Force
Microscopy
AFM based nanolithographic techniques have been already mentioned as very
versatile methodologies for a highly controllable manipulation of matter at the nan-
oscale. First attempts of modifying surfaces with SPM date back to 1990 when
Eigler and coworkers (75) reported the use of STM in ultra high vacuum to slide
single Xenon atoms to compose the IBM logo.
With the advent of AFM, matter manipulation at the nanoscale was not any-
more confined to low temperature, high ultra vacuum environments, and a few years
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Figure 3.2: Single Xenon Atom Manipulation with STM - Construction of IBM
logo manipulating step-by-step single Xe atoms on Ni surfaces. Adapted from (75).
later the two major widespread AFM based lithographic techniques were introduced,
namely nanografting (76), 1997, and Dip Pen Nanolithography (59), 1999. Even lo-
calized tip induced in situ chemical reaction can be performed, using conductive tip
AFM to induce electro-oxidation on the substrate, like, for example, nanoelectro-
chemical patterning, in which the tip is used to convert electrochemically the head
group of a monolayer into another functional group. This technique however cannot
be performed in liquid and is not therefore suitable for successful immobilization of
protein in native-like conditions.
3.2.1 Dip Pen Nanolithography
The invention of Dip-Pen Nanolithography (DPN) dates back to 1999 (59). Con-
ceptually, it isn’t very much different from µCP, or molecular stamping, but makes
good use of the high lateral resolution of AFM combined with the self assembly
capability of molecules like alkylsilane on silicon oxide, and thiols on gold. It is a
nanoscale top down approach to delivery, coupled to a bottom up approach to spon-
taneous molecular organization. It is a scanning-probe based patterning technique
in which molecules could be directly transported repeatedly from a molecule-coated
tip (previously dipped in an “ink” reservoir) to a surface in an additive manner, as
shown in figure 3.3. Molecules that serve as inks are coated on an AFM tip and
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Figure 3.3: Cartoon of Dip Pen Nanolithography technique - A tip, previously
dipped in a solution of a thiolated molecule, is scanned over the surface to deliver
molecule at specific location. The size meniscus of the meniscus influences the
thiols tranfer to the surface, and therefore has to be carefully controlled through a
humidity chamber. Adapted from (59).
transported to the surface by engaging the tip and scanning. Inks that chemisorb
specifically and self assembly on the surface are preferred to generic physisorbing
molecules. The patterns are produced in a binary one-to-many array configuration
(one molecule, many spots) with physical architectural parameters controlled by the
movement of the AFM tip. DPN utilizes the water meniscus that naturally forms
at the point-of-contact between tip and surface to help control ink transport, and
therefore requires a humidity-controlled chamber to regulate ink transport. The
remainder of the surface is then passivated to prevent non specific binding in subse-
quent uses of the nano array. The introduction of multiple cantilevers array boosted
the application of DPN for the simultaneous fabrication of highly dense parallel ar-
ray of molecules, in which patterns feature size of about 100 nm × 100 nm (58).
Then, with the introduction of hollow cantilevers arrays, in which the tip is actually
a sort of nanopipette dispenser, multiple proteins can be patterned in haglhy dense
array for subsequent high-throughput applications.
It has been argued that (57) DPN is the only AFM-based nanolithography that is
actually based on the delivery of molecules on the surface without any simultaneous
delivery of energy, and that this makes DPN the only constructive (as opposed to de-
structive) technique. DPN, like all bottom up approach, exploits the self assembling
properties matter, hence supplying energy to the molecules is not necessary for the
assembly to happen. However, introducing energy into the system opens alternative
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self-assembly pathways, that can lead to facilitate route of spontaneous organization
of the desired molecules. If the energy delivery is accompanied by the introduction
of appropriate additional boundary conditions, like physical confinement, the spon-
taneous organization in self assembled pattern can be not only enhanced but also
modulated and controlled actively. This is what nanografting does.
3.2.2 Nanografting
Nanografting was reported in 1997 by Liu and coworkers (76). It is an AFM nano-
lithographic based techniques combined with the surface chemistry of thiol adsorp-
tion on gold surfaces, with a ten better resolution than the much more widespread
DPN. The procedure of nanografting is relatively simple. Starting from imaging
(under a small force) an alkanethiol SAM in a liquid medium containing a different
kind of thiol that has to be patterned, by scanning at increased loading force, the tip
catalyses the substitution of the existing monolayer and favours the self assembly
of the new molecules in the chosen area (cf. Figure 3.4, panel a). The accelerated
chemisorption rate is attributed to a change in the pathway for the self-assembly
process. The spatial confinement makes it geometrically more probable and en-
ergetically more favorable for the initially adsorbed thiols to adopt a standing-up
configuration directly in this microenvironment. It has been shown by SPM and
diffraction studies that spontaneous self assembly of thiols onto gold surfaces in an
unconstrained environment involves a two step phase. Initially, molecules attach to
the gold with the chains parallel to the surface, a reaction intermediate known as
the lying-down phase; then, as a result of collisions and lateral pressure, thiols pack
in a standing up phase with a tilt of 30◦ to the surface normal. (64, 77)
Nanografting is thought to alter the initial Langmuir (or modified Langmuir)
kinetic pathway of molecule adsorption (77), basically lowering the activation en-
ergy for the spatially confined self-assembly process. While scanning at high loading
force, the tip creates a transient reaction environment in which the newly exposed
gold surface is spatially confined by the surrounding thiols and the tip. The adsorb-
ing thiols, present at high local concentration compared to that of the desorbing
ones, are restricted in a confined area so that the “laying-down phase” is skipped
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Figure 3.4: Cartoon of Nanografting technique - a) Nanografting process. b)
topographic images of C18 self assembly on gold, as a function of time and of the
surface reaction pathway. After a portion of the surface is shaved (i.e. bare gold is
exposed), a solution of C18 molecule is incontact with the sample. Self assembly
in spatially confined process like nanografting is much faster than the spontaneous
self assembly in unconstrained condition. Adapted from (64).
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and thiols readily adopt the “standing up” configuration. The standing-up configu-
ration facilitates the chemisorption of sulfur to gold and the packing of the chains
to form the SAM, and it is also enthalpically favorable because the interactions be-
tween the newly adsorbed molecules and the surrounding thiols help stabilizing the
transition states for the self-assembly process. It has also been shown by SPM that
the order and packing of the nanoassembled monolayer is considerably higher than
in unconstrained SAM adsorption.
This nanolithographic technique has been chosen for tunable surface nanopat-
terning of a variety of molecules, including alkanethiols as internal reference for
accurate measurements of electronic properties of molecular junctions (78), DNA
oligonucleotides for surface hybridization studies (63) and protein interaction stud-
ies (66), and a variety of suitable linker for protein immobilization that will be
addressed in the next section (61, 62, 65, 67, 79, 80). Many variants of nanografting
have been proposed, and are referred to as reversal nanografting, when the inert
molecule is patterned into a SAM of desired surface functionalization, and tapping
mode nanografting, when patterning is achieved not in CM-AFM as usual, but
in AM-AFM with strong intermittent interaction between the tip and the sample.
3.2.3 Native Protein Nanolithography
Native Protein Nanolithography has been introduced in 2008 by Tinazli et al
(60). It can be described as an “erasing technique”: a SAM, already functionalized
with a protein of interest, is then scanned in a particular variant of the AM-AFM
mode, a second vibrational AFM mode that was named as contact oscillation mode.
Immobilized proteins are detached by the tip and replaced by other proteins, which
are selectively self-assembled from the bulk. The technique relies upon selective re-
moval at specific location of a “protecting protein” and on the self assembly of desired
his-tagged proteins on a SAM presenting Ni(II)-loaded NTA functional groups, and
in principle can be applied to any SAM derivitized with proteins (or other macro-
molecules) via affinity capture system.
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3.3 Nanografting as a tool for protein immobiliza-
tion
Technically, nanografting is performed in a closed liquid cell were the substrate
carrying the hosting SAM is mounted. The cell is filled up with a solution of the
thiolated molecule that has to be patterned. Since the hosting SAM is usually made
of alkylthiols, not so prone to water solubility, ethanol, 2-butanol, or an aqueous
solution containing a certain percentage of ethanol or trifluoroethanol (TFE) has to
be employed. Small percentages of organic solvent can be tolerated by many proteins
(but not all); among them, TFE is well known and widely used because it promotes
intramolecular hydrogen bonding formation to the detriment of solvent (water) -
protein interactions: α-helix secondary structure is, for this reason, promoted and
stabilized by TFE addition. In some occasion, reducing reagent like TCEP(tris(2-
carboxyethyl)phosphine) can be added to maintain thiol groups in the reduced state.
Unlike DTT or mecaptoethanol, TCEP is not involved in the exchange reactions with
self-assembled mono- layers (SAMs) of thiols.
SAM are firstly imaged in liquid at low load to select the area where to fabricate
the nanostructures. The desired patches are usually obtained within the SAM by
scanning the AFM tip at considerable loading force (above a threshold of, let’s say,
70 nN) in a confined area of desired size. In this way the alkylthiol SAM phase is
exchanged with the thiolated linker or protein. The rate at which the tip is scanned
over the selected area may influence the process especially if bulky molecules are
involved. With nanografting, molecule’s packing density can be routinely varied in
a reproducible manner by operating on two parameters: primarily by varying the
concentration of the grafting solution, and secondarily by changing the ratio between
the actual area scanned by the tip and the area of confinement (scan density ratio,
as schematichally drawn in figure 3.5. Tuning these multiple parameters, even in
the same experimental run, allows the user to tailor the fabrication technique to
the particular molecule to be pattern. Moreover, the use of a hosting SAM with
“bioresistant” properties (i.e. oligoethylenglycole terminated SAM) provides an inert
internal reference, that allows for intrinsic differential measurements of interfacial
properties on the nanostructures.
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Figure 3.5: Surface density moculation via Nanografting - Molecule’s packing
density tuned by changing the scan density ration Rtip · lines/area, that is the ratio
between the actual area scanned by the tip and the area of confinement. A visual
cartoon is depicted in the specific case of a tip/surface contact area diameter of 10
nm, image size of 160×160 nm2, and the number of line wrote by the tip on the
fast scanning direction (pixels) indicated in the three cases.
3.3.1 Probing lateral heterogeneity of protein structures with
nanografting
Liu and coworkers reported recently (67) the use of nanografting and reversal
nanografting to study the effect of size and distribution of functionalized nanoscale
spot (as little as 25 nm2) on subsequent protein immobilization. Strong dependence
on the dimension and spatial distribution of protein binding sites within arrayed
pattern were investigated in antibody recognition, covalent attachment via primary
amine residues and surface-bound aldehyde group. The coverage as well as the
orientation of protein molecules was regulated, to a large degree, by changing the
dimension and separation of each nanoelement, in the case of biotin and antibiotin
IgG reactions over biotin nanopattern, and by changing the nanografting conditions,
in the case of covalent immobilizations of IgG and Lisozyme on aldehyde terminated
thiols. The study dealt mainly with the AFM study of the later heterogeneity and
protein distribution after immobilization on these nanostructured interfaces, but it
was not investigating how these interfacial properties were influencing the stability
and functionalities of those proteins.
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3.3.2 Direct Nanografting of Cysteine-tagged protein
Direct linking of proteins to a gold surface is provided with the introduction of an
extra (or multiple) cysteine at the N- or, more often, C-terminal of the protein. The
proximity of the gold surface poses some concerns about the folding stability of the
polypeptide to be immobilized, so initial experiments were performed on de novo
combinatorial peptides of know stable folding (79, 80), and later on, native protein
nanografting was achieved with recombinant Maltose Binding Proteins (61).
de novo three-helix bundle peptides can be chemically synthesized from well
established computational design of motifs such as coiled coils. Such systems can
be selectively assembled by appropriate choice of hydrophobic core residues. For
example, a repeat of the hydrophobic amino acids leucine (L) and valine (V) at the
first and fourth positions of a heptad of amino acids has been reported to confer
trimeric specificity (80). For peptides shorter than 30 amino acids, however, such
specificity may not be as marked, so Case et. al. chose a design that exploited the
coordination requirements of transition metal ion in order to dictate the topology of
the resulting threepeptide ensemble. A 78 amino acid iron(II) complex [Fe(RpVaLd-
C26)3] was nanografted into a C18 alkanethiol monolayer previously assembled on
a Au(111) surface and characterized by AFM.
Specifically, each peptide had a bidentate 2,2’-5-carboxy-bipyridyl ligand ap-
pended covalently via an amide linkage to the N terminus. Addition of ferrous ion
sequesters the three peptide ligands to form the octahedral [Fe(bpy)3]2+ complex,
thus increasing the effective local peptide concentration. The ensuing hydrophobic
collapse of the interior of the structure is accompanied by folding of the tertiary
parallel three-helix bundle protein architecture. The folded structure is designed
to present the C-termini of the three helices to an appropriate surface in a tripo-
dal manner, where, to enable the necessary chemisorption on gold, the helices were
terminated with D-cysteine residues. D-cysteine is a “non natural” aminoacid (the
one biosynthesized by living organism is L-cysteine), but was choosen because the
unnatural D- stereochemistry presents the thiols coaxially with the helices rather
than equatorially, which would be the case were L-cysteine to be employed. The
nanopatterns were then imaged at low forces to ensure the effective immobilization
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via height (topographic) measurements. Differential height measurements with ref-
erence to the hosting C18 SAM gave an average value of the height difference is 3.1
nm, implying a measured height for the proteins of 5.3 nm,in very good agreement
with the 5.2 nm size extrapolated from molecular model. Increasing loading forces
showed that these peptide nanostructures of 100 nm × 100 nm are resistant to me-
chanical load up to 15 nN; then they become damaged.
Interestingly, experiments were also attempted using the truncated 19-residue
analogue [Fe(RpVaLd- C19)3]2+, however, the patterning showed a broad distribu-
tion of low heights (0.8 nm). It is likely that the hydrophobic gold surface promotes
unfolding the three-helix bundle upon contact, and the additional 900 cal×M−1 sta-
bility conferred by the additional two turns per helix in [Fe(RpVaLd- C26)3]2+ is
necessary to overcome this thermodynamically driven unfolding.
De novo helix bundle combinatorial proteins were nanografted and charac-
terized onto the (111) surface of gold (79). The particular protein used in this second
study on synthetic proteins was recombinant engineered to contain a Gly-Gly-Cys
linker at its C-terminus,1 and the protein was named S-284-C, since it is based on
the previously characterized S-824 de novo protein. S-824 was chosen from a“binary
cod” strategy library of 102-residue sequences designed to fold into 4-helix bundles.
The 3D structure of S-824 was determined by NMR, and as specified by the binary
code design, it is a 4-helix bundle with a polar exterior and a hydrophobic core.
Compared to the previous case, Hu and coworkers reported that nanografting
this bulky protein (compared to the sinthetic peptide) was a very delicate process.
The average height of the grafted protein patterns was found to be somewhat higher
than expected from the known NMR structure of the protein: measured heights
placed the top surface of the protein approximately 5-8 nm above the gold surface,
whereas the expected height would have been 5.5-5.8 nm above the gold surface.
The entire protein (MW > 12 KDa) was bound to the gold surface by a single thiol
linker at the C-terminus of the protein, with a much smaller cross-section than the
4-helix bundle protein. Therefore, if all the sulfhydryl groups in the solution seek the
1Please note that the protein was produced via recombinant DNA techniques, that is, bacterial
cells were forced to produce the protein from a properly transfected DNA sequence. Therefore,
the cysteine introduced as a tag is a L-cysteine, the natural enantiomer
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Figure 3.6: Direct Nanografting of de novo polypeptides - Cartoon depict-
ing stable polypeptide immobilization through nanografting of (top) [Fe(RpVaLd-
C26)3]2+, and (bottom) combinatorial protein S-284-C. Adapted from (79, 80).
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gold surface, then there would not be sufficient space for the 4-helix bundle proteins
to pack, a situation that Hu and coll. depict as “packing mushrooms”: if the vertical
stems achieve close packing at their bases, then close packing will not be possible for
the mushroom caps. This effect might destabilize the formation of 4-helix bundles
in the nanografted patches and favour protein refolding upon adsorption to the gold
substrate, thereby producing a long 2-helix hairpin.
Compression of the nanografted patches by an external force (below 10 nN) was
reversible but showed some hysteresis. Interestingly, both the energy required to
deform the immobilized protein patterns and the energy defined by the hysteresis
loop were found to be of the same order (43 kcal/mol) as the energy required to
unfold the monomeric protein in solution, putting the basis for measuring the energy
stored in proteins by mechanical compression as a method for probing the structural
stability of proteins packed at high density.
Maltose Binding Protein (MBP), engineered with a C-terminal double cysteine
tag, was effectively nanografted by Staii et al onto EG3 (triethyleneglycole) termi-
nated SAM grown on gold (111) surface in native conformation, and in situ bioactiv-
ity of these proteins within the fabricated nanopatterns was assessed through lateral
force measurements, as illustrated in figure 3.7. Protein ligand-binding function was
maintained upon the immobilization process and was not affected by the addition
of the cysteine dipeptide, the spatial confinement associated with nanografting, and
the interaction between the protein and the Au substrate.
Maltose Binding Protein belongs to the superfamily of the Periplasmic Binding
Proteins, involved in bacterial chemotaxis and uptake of nutrients in the surrounding
environment. MBP has a binding domain able to recognize sugars like maltose and
maltotriose. Upon binding, the ligand (e.g. maltose or maltotriose) is buried into the
the binding cleft, and the protein undergoes a conformational transition. However,
the contribution in height is negligible, so the binding events had to be detected
through friction measurements. The maltose (or maltotriose) mediated conforma-
tional changes within the MBP have been found to change the AFM-tip-protein
interaction, therefore causing the frictional signal to change. The authors stud-
ied the change in the frictional force above the protein nanopatterns as a function
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Figure 3.7: Direct nanografting of MBP in native conformation - MBP-Cys2
was nanografted efficiently in stable conformation. Biochemical activity (maltose
or maltotriose binding) was ascertained through friction force measurements: the
normalized friction force (as compared to the surface) was proportional to MBP
saturation. Adapted from (61, 65).
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Figure 3.8: Friction Force based binding tudies. - Sigmoidal dose-response
curve of normalized friction force as a function of ligand concentration allows
for accurate estimation of binding parameters apparent dissociation constant
for the MBP-cys-cys/maltose system to be Kdmaltose = (1 ± 0.04)µM, and
Kdmaltotriose = (0.22±0.01)µM for the maltotriose ligand. Adapted from (61, 65).
of maltose or maltotriose concentration, and they determined apparent dissociation
constant for the MBP-cys-cys/maltose system to be K
dmaltose = (1±0.04)µM, and
K
dmaltotriose = (0.22 ± 0.01)µM for the maltotriose ligand, which is close to the
value of 0.16 µM reported in the literature for proteins in solution using both fluo-
rescence and rapid-kinetic techniques. The particular orientation of the nanografted
MBP-Cys2, which exposes the binding sites to the buffer solution, facilitates the
the accessibility of ligand binding sites without impinging on the determination of
apparent binding affinities.
3.3.3 Nanografting of DNA as a tool for DNA directed pro-
tein immobilization on nanoarrays
Nanografting of thiolated oligonucleotides is a well-established techniques, that
aimed at the very beginning at the understanding how spatial confinement in lo-
calized spot on an array affects the performance of the devices, especially referring
to hybridization of complementary target sequences. ss-DNA oligonucleotides (be-
tween 15 and 60 bases) functionalized with a HS − (CH2)6− linker at the 5’ 1,
are nanografted onto EG3-SAM grown on templated stripped gold, in a mixture
1depending on the application, a 3’ modification can be introduced
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of buffer and ethanol (with ethanol usually not exceeding 50 %). SENIL labora-
tory has developed a solid expertise in the controlled immobilization of thiolated
DNA probes via nanografting (62, 63, 66) and how the ordered packing of probes
within the nanografted patch allows for the exploration of hybridization pathways
otherwise not accessible to the conventional DNA SAM. In fact, nanografted DNA
structures allowed for hybridization efficiency considerable higher than those re-
ported on conventional self assembled surfaces. The hybridization efficiency was
effectively probed with topographic measurements and with the investigation of the
viscoelasticity properties of ss-DNA and ds-DNA nanostructures as a function of
an applied external force, even in direct comparison with adjacent unconstrained
SAM of the same DNA (63). These DNA nanostructures have been used also to
investigate the effect that the steric hindrance introduced by surface bound DNA
nanostructures have restriction enzyme reactions (66).
Interestingly, ss-DNA nanoarrays can be easily transformed into protein nanoar-
Figure 3.9: Cartoon of DDI protein immobilization on nanografted DNA-arrays
- Complementary thiolated ssDNA is nanografted into an EG3 SAM. The protein
of interested, chemically linked to ss-DNA, is then immobilized specifically through
base pair recognition. AFM topographic profiles are used to assess protein immo-
bilization on the surface. Adapted from (62).
ray if the surface is hybridized with a complementary oligonucleotide strand con-
jugated the protein of interest, as shown in figure 3.9 (62). Then, biorecognition
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events can be detected by topographic measurements (a label free approach) even
in complex matrices. The combination of nanoscale parallel fabrication of multiple
sequence array with the DNA Directed Immobilization (DDI) of proteins has been
proven able to immobilize specifically different proteins in an array configuration in
active conformation, to recognize the cognate antibody without loss of affinity, and
to detect selectively the same specific antibody even in a complex matrix like stan-
dardized human serum. In the latter case, a patch array of three different ssDNA
sequences was fabricated, in order to produce a negative control spot, a spot for
DDI immobilization of streptavidin (STV), and a third spot for DDI immobilization
of glucose oxidase (GOx). The two DNA-protein conjugates hybridize specifically
Figure 3.10: Multiprotein nanoarrays via nanografting and DDI - Use of
nanografted oligonucleotide patches for specific immobilization of proteins and on
their subsequent use for label-free detection of protein binding interactions.
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on their respective complementary strands on the surface, as detected in the topo-
graphic profile. Two specific antibodies, anti-STV IgG and anti-GOx IgG dissolved
in BISEKO (standardized human serum) matrix, were allowed to bind to this array,
and each binding was monitored sequentially by topography measurements. The
profile shown in figure 3.10 show clearly that both antibodies could be detected and
no indication of nonspecific binding of either matrix components or target proteins
disturbed these analyses.The observed specificity of biomolecular recognition and
the lack of nonspecific binding confirm the suitability of nanografted patch arrays
for applications in biosensing.
3.3.4 Nanografting of NTA-thiols: a platform of general ap-
plicability for his-tagged protein immobilization
NitriloTriacetic Acid terminated thiols borrowed the metal chelation affinity
trapping of protein from purification protocol. Mixed SAM containing NTA-terminated
thiols diluted in a EG matrix have been largely and successfully used for protein
immobilization and binding studies (protein-protein interactions, protein-ligand in-
teractions, (44, 46, 81)) through surface techniques, namely Surface Plasmon Res-
onance and its commercial devices like Biacore and IASys (49, 53). Preparation
of these mixed monolayers was achieved from in situ chemical functionalization of
SAM with NTA head groups or, more conveniently, from mixed solutions of NTA-
terminated thiols in the form of HS − (CH2)16−EG3−NTA and a filler one, like,
for example, EG3-terminated thiols. Like all protocols for protein immobilizations,
preparation of NTA SAM has to take into account many factor, like the miscibility
of the thiols and the density ratio between the two molecules, so to maximize the
number of binding site for the protein without posing steric hindrance concerns.
NTA-surfaces are very attractive to surface biochemists’. Considerable amounts of
extremely pure proteins are required for specific protein immobilization, request that
is not easily fulfilled when protein are purified from biological specimen. The emer-
gence of recombinant techniques for overexpression in suitable organisms equipped
researchers with tools for quantitative production of desired proteins. As already
mentioned in section 2.2.2.3 a mean for efficient purification and recovery of recom-
binant protein is the His-tag, a peptide easily fused to proteins virtually without
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pitfalls. The imidazolic nitrogens of two histidines in the tag complete the octahe-
dral coordination of Ni (II) trapped onto NTA, that with his three carboxylic acid
and one nitrogen occupies the other four positions. This chelation is reversible and
effectively displaced by histidines competitors, like concentrated imidazole solutions,
so re-usability of the surface is possible. The affinity of this chelation was measured
to be 10µM in solution, but the binding strength on surfaces increases at least ten-
fold, with a dissociation constant of 1µM. However, density of the NTA moieties
on the surface is known to play a major role in the stability of the functionalized
surfaces.
Affinity of NTA-thiols has been improved in recent years by Piehler and Tampe’s
group (54) with the use of multivalent chelator (MCHs) agents like thiols with multi-
ple NTA headgroups (where “multivalent” refers to the global NTA moiety). Single
component and EG3 mixed SAM of mono-, bis- and tris- NTA-terminated thiols
were extensively characterized by means of contact angle goniometry, ellipsometry,
and infrared spectroscopy, showing superior properties of MHCs compared to mono-
valent chelators, and providing informations for a deep understanding of the effects
of the charged and hydrogen bond accepting/donating within NTA groups on the
packing of NTA-terminated thiols on solid surfaces.
Single component SAMs of NTA-thiols, whether mono- or multi- valent, show
increasing density of thiols on the surface with increasing molar fraction of the same
molecule in loading solution up to 80 mol%, above that the bulky NTA groups in-
teract laterally upon formation of the SAMs on the surface, and a densely packed
assembly of alkyl chains in an extended all-trans conformation is no longer possible.
A contribution of disturbing lateral interactions between the EG3-linker in between
the chains cannot be excluded (45, 54).
EG3 mixed SAM of mono-, bis- and tris- NTA-terminated thiols showed a criti-
cal molar ratio (in % terms) in the loading solution above which the disorder of the
SAM and phase separation phenomena start to appear. Molar ratios 0-30 mol %
of the NTA thiols with respect to the filling EG3 molecule resulted in mixed MCH
SAMs containing a densely packed alkyl layer, an amorphous ethylene glycol layer,
and an outermost layer of NTA groups exposed to the ambient (54).
Valiokas et al. provided also a functional characterization of ligand (His-tagged
proteins) binding kinetics and reversibility, showing that higher densities of NTA
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trigger surface steric hindrance in protein immobilization, a phenomenon that is
emphasized with the use of multivalent chelators; the same MCH are, on the other
hand, offering a more stable surface. It was previously reported that long His-tags
likely cover multiple NTA moieties, even when monovalent chelators are used, and
that in the presence of higher density of NTA neighbouring groups rebinding effects
contrast the dissociation of his-tagged proteins from the surface. A modulation of
NTA-thiol density provides, therefore, a mean for tunable immobilization proper-
ties.
In contrast to spontaneous self assembly from solution, that requires a strong
dilution of NTA-thiols into matrix thiols to yield ordered NTA-containing SAMs,
nanografting offers a unique route to nanopatterned NTA-patches with high lo-
cal concentration without compromising molecular packing and order, as already
demonstrated for alkanethiols. For this thesis, we chose to nanograft monovalent
NTA-EG3-(CH2)16-SH1 in a EG3-(CH2)11-SH matrix. Ethanol solutions of NTA-
thiol in the concentration range 14÷450 µM were effectively nanopatterned; above
that range, clustered aggregation of physisorbed and chemisorbed molecules was
observed, while below that range, thiol substitution was inefficient. The nanostruc-
tured patches served for subsequent functionalization with two different his-tagged
Fragment of antibodies that were able to provide oriented immobilization of recom-
binant mouse prion protein. Next chapter will detail the bichemical characterization
of these nanostructured interfaces.
1kindly provided by prof. Jacob Piehler
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4Oriented PrP immobilization
We show here that nanografting enables to immobilize recMoPrP(89-230) in an
oriented manner and to study its interactions by means of carefully executed to-
pographic measurements on a very flat surface 1. As a substrate, a very flat gold
film covered by a monolayer of alkane-thiol supported triethyleneglycol serves as a
reference which we call “the carpet”.
After functionalization of the substrate with one of two different Fabs (antigen
binding fragment of antibodies) and topographic measurements in Contact Mode
(CM) AFM in a liquid environment, we were able to detect not only the successful
recognition of recMoPrP(89-230), but also the two different orientations of the PrP
in the two different orientations. The differential height increase (between two sub-
sequent steps) over the nanopatches is in good agreement with the molecular size of
the immobilized protein. To this end, we compared our experimentally determined
topographic heights with previously published NMR and or crystal structures.
4.1 Experimental design
Metal complexes like Ni2+-NTA are commonly used in affinity purification and
immobilization strategies (52, 53), since they allow for reversible affinity capturing of
histidine tagged proteins in a known orientation. Previously, micro and nanopattern-
ing of NTA-functionalized SAMs have been exploited for oriented immobilization of
1Sanavio B., Scaini D., Grunwald C., Legname G., Scoles G., Casalis L., submitted to ACS
Nano.
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Figure 4.1: Cartoon of the oriented immobilization of recMoPrP(89-230) on
Fab-derivatized surfaces, with average height profile resulting at each step
of the assay (pH 7.4). - After nanografting of NTA-EG3-C16-SH into a reference
carpet of protein repellent EG3-C11-SH, histidine-tagged Fabs (CloneP, on the left,
and D18, on the right) are immobilized in different experimental runs taking ad-
vantage of His-tag-Ni-NTA interaction on the nanopatches. Afterward, the sample
is incubated in a solution containing recMoPrP(89-230) 300nM. At each step of
the assay, topographic measurements (CM-AFM profiles are reported here) are
collected for each nanopatch. Protein models are based on previously published
structures (e.g., see 1hh0.pdb, for Fab (82), and 1qm0.pdb, for recMoPrP (83)).
RecMoPrP structures are drawn at the same scale when oriented on the two differ-
ent Fabs; blue tail represents the unstructured part not resolved by NMR spectra,
where CloneP binds, D18 epitope is colored in green.
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targeted proteins (53, 54, 60). Here, however, by coordination of Ni2+, two different
histidine tagged recombinant Fabs, D18 and Clone P, were separately immobilized
at controlled density and orientation, on nanopatches, allowing for optimized and
oriented immobilization of the recMoPrP(89-230), a truncated recMoPrP that lacks
largely of the unstructured N-terminal region. CloneP (70) and D18 (84) have been
extensively studied in vivo and also in vitro in their binding properties towards
PrPC and PrPsc and the recMoPrP. D18 recognizes the epitope spanning residues
132-156, that is considered important in the prion replication, while CloneP blocks a
stretch of positively charged aminoacid spanning residues 95-105 in the very flexible
N-terminal part.
Figure 4.1 reports an example of height profiles recorded with reference to the sur-
rounding carpet of EG3-thiols, and the specific height increase over the patch at
each step is neatly recorded by AFM topographic measurements. Nanostructured
surfaces were used to capture in controlled orientation recMoPrP(89-230) in two
different buffer conditions to study the effect of pH on protein immobilization. At
pH 7.4, at physiological condition, the two differently Fab functionalized surfaces
were exploited as an immunoassay to capture the target recMoPrP(89-230) at dif-
ferent concentrations and to perform binding studies. At pH 5.8, near the pH at
which the recMoPrP(89-230) is refolded after purification, we captured the protein
on the functionalized nanostructures to detect by topography the effect of pH on
the immobilization and on the recMoPrP itself, since effect of pH on conformation
and charge distribution have been reported.
4.2 Topography Detection of Oriented Immobiliza-
tion of recMoPrP(89-230)
After nanofabrication, NTA nanopatches (varying in size from 0.5×0.5µm2, 128
lines, and 1 × 1µm2, 256 lines) were functionalized with the two different Fabs at
pH 7.4 in TBS (Tris Buffered Saline, 20 mM TRIS buffer, 150mM NaCl), that is
compatible with the reported affinity studies(70, 84) on PrP both in vitro culture
and with SPR (Surface Plasmon Resonance). Topographic measurements using
CM-AFM were conducted to discriminate the orientation of the molecules.
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4.2.1 Characterization of NTA-Nanopatches
NTA patches imaged in ethanol during the nanografting process showed a height
increase over the carpet of 3.5 ± 0.4 nm (± Standard Deviation, S.D., as for other
errors reported), in agreement with the theoretical difference expected from the
molecule’s theoretical length (85) (theoretical height difference is 3.5 nm, see Ap-
pendix 5 for further details).
In contrast to spontaneous self assembly from solution, that requires a strong
dilution of NTA-thiols into matrix thiols to yield ordered NTA-containing SAMs
(NTA thiol could be mixed only up to 30 mol%),34 nanografting offers a unique route
to nanopatterned NTA-patches with high local concentration without compromising
molecular packing and order, as demonstrated for alkanethiols (76).
The same patches imaged right after nanografting in TBS, however, showed a
height increase of 2.3 nm ± 0.3 nm over the surrounding SAM (Figure 4.2). The
carboxylic groups of the NTA moieties on the top of the supporting thiol (NTA-EG3-
C16-SH) are ionized, and strongly negatively charged, at pH 7.4, so that electrostatic
repulsion between adjacent head groups may induce relaxation or “opening” of the
NTA head groups themselves, leading to an overall lower height. This observation
was confirmed by studying the influence of the pH during imaging (see following
sections) and by comparing the height of the patches right after fabrication in ethanol
that is a less polar environment.
4.2.2 Characterization of Fab-finctionalized Nanopatches
Once derivatized with either D18 or CloneP, the surface of the patches did show
a height increase of 2.0 nm ± 0.4 nm for D18 and 1.8 nm ± 0.3 nm for CloneP,
suggesting both loose packing and tilted orientation of the antibody. In fact, looking
at the molecular size taken from the structure of an analogue of CloneP (2hh0.pdb
(82)), the Fab would present a long major axis of about 5.6 nm, assuming that it seats
straight and extended over the patch. However, if the antibody fragment was free to
rotate over the blocked histidine tail, just a slight inclination of the major axis would
explain a measured height of half than expected, as the vertical projection of the
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Figure 4.2: Oriented immobilization of recMoPrP(89-230) at pH 7.4 - Oriented
immobilization of recMoPrP(89-230) at pH 7.4 (20mM Tris, 150 mM NaCl) on D18
(left column) and CloneP (right column) functionalized patches. Differential height
contribution relative to the NTA-thiol patch, the Fab immobilization (D18 or CloneP,
respectively left and right), and recMoPrP are shown. All values are given ±
Standard Deviation, (S.D.), as derived from two independent experiments of four
nanopatches each.
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molecule size is now smaller. Slight differences between the measured average heights
of two Fabs, CloneP and D18, may be due to both differences in the two individual
structures and in the packing during self-assembly over the NTA nanopatch.
Orientation specific docking of CloneP and D18 on NTA-nanostructures was im-
mediately evident from topographic imaging of the surface (see Figure 3). Generally,
we found that surface roughness provides an additional read out that can help iden-
tifying different protein-surface interaction scenarios. In case of specific interactions
(see Figure 3), we found a clean EG3-SAM with modest variation in roughness (Rq
between 0.3 nm before any fabrication step, to the 0.6 nm average roughness of
the surface at the end of the assay after recMoPrP immobilization). For a con-
taminated carpet due to unspecific protein interactions, we observed (in a few well
identifiable occasions) a significant increase in roughness (>1nm). The roughness of
the nanografted patch, that was relatively smooth at the NTA-fabrication step (on
average, 0.6 ± 0.1 nm), increased as the Fab was immobilized, to 1.0 nm ± 0.3 nm
for CloneP, while it remains constant around 0.6 nm ± 0.3 nm for D18.
Figure 4.3: Topography images in TBS pH 7.4 in CM-AFM. - a) NTA nanopat-
terned at 1× 1µm2, 256 lines; b) same patch after CloneP immobilization; c) after
recMoPrP immobilization (300 nM), and d) after regeneration with TBS 400mM
Imidazole. Color scale is adjusted to be the same in all images.
4.2.3 Capturing recMoPrP(89-230) in selected orientation
The surfaces were challenged with a 300 nM solution of recMoPrP(89-230), a
concentration high enough to ensure patch saturation. This concentration is in fact
more than 100 times the known dissociation constants for both the two Fabs, thus
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allowing for more than 99% fractional occupancy of the binding sites. As indicated
by the increase in height, the two Fabs were able to recognize their antigen. From
properly oriented molecules in structure (pdb) files, obtained from previously pub-
lished mouse PrP NMR data (83, 86, 87), we expected an overall protein size of
about 3 nm on the D18 functionalized patches, and of about 6 nm on the CloneP
derivatized ones. These expectations were in very good agreement with the data
shown in Figure 2. CloneP and D18 capture the recMoPrP(89-230) exposing differ-
ent surfaces and different morphologies to the AFM tip: the two distinct increases
in height are due to the oriented recognition of the PrP by the Fab-functionalized
nanopatches and reflect the expected molecular size of recMoPrP, as 6.2 nm ± 0.8
nm over the CloneP-nanopatch and 3.0 nm ± 0.8 nm over the D18 functionalized
structures.
To further confirm the extrapolated size with experimental data, another immo-
bilization chemistry has been tested. RecMoPrP(89-230) was covalently linked to
nanografted patches of carboxylic acid terminated thiols (HS-C15-COOH), activated
to react with free amine groups of lysine side chains on the protein surface, giving
an height of about 4 nm, but with a rough and inhomogeneous surface (see figure
4.4). The roughness was further enhanced by binding of D18 because, in this case,
Figure 4.4: Covalent immobilization of recMoPrP(89-230) - a) Nanografted
patches of (HS-C15-COOH), and b) covalent crosslinking of recMoPrP(89-230)
the proteins do not present all the binding sites oriented in the same way, so not all
of them are available for recognition by the corresponding antibody.
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4.3 Antibody/recMoPrP(89-230) Recognition as a
Function of Protein Concentration: Apparent
Binding Constant Measurements
4.3.1 Primary results
Biorecognition efficiency of recMoPrP on the two functionalized nanostructured
interfaces was investigated through the estimation of apparent affinity constant (as
apparent dissociation constant, Kdapp), after titration as a function of recMoPrP
concentration. SPR affinity data were already reported in the literature(70, 84) for
measurements at pH 7.4, the same condition we chose, and these data can be used
to compare how nanofabrication and surface assembly may affect the immunoassay
performance.
CloneP-functionalized surfaces were titrated against recMoPrP(89-230) con-
centrations ranging from 3 pM to 300 nM, and the average differential height in-
crease due to deposition of the PrP molecules on the Fab functionalized patches
was monitored. Differential height increase is related to specific binding onto the
nanostructure and, of course, it increases as a function of the specific coverage on
the spot. The height response (∆h) of recMoPrP, as well as the roughness signal,
was used to estimate an apparent affinity parameter (see Figure 4).
The derived apparent affinity (Kdapp) of the molecule for the functionalized sur-
face, that we measure to be 3 nM ± 1 nM (1.5 nM ± 1.3 nM from the roughness
signal), equals or is up to 10 times larger than the estimated CloneP affinities for cog-
nate epitope measured on macroscopic surfaces which ranges between 0.3 (hybrid
mouse and bovine engineered protein), 0.5nM (Bovine peptide spanning residues
95-145), and 2.6 nM (Human peptide 95-145), as previous SPR characterizations re-
ported (70). At a concentration of target equal to the Kd concentration, let’s say 0.5
nM recMoPrP concentration in this case, on average half of the Fab molecule would
be complexed, that is, half saturation is reached, and the response signal is propor-
tionally decreased compared to the (almost) fully saturated one. We expect that, in
addition to experimental error, the probably closer packing of the molecules induces
the steric hindrance that is responsible for the deviation from the bulk surface value
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(88, 89). Indeed the roughness signal, in our case connected to the coverage on the
nanopatch surface, correlates slightly better with the results obtained on extended
surfaces employing SAMs. We may argue, though, that SPR data, fast and use-
ful on large scale studies, have actually little control over molecule orientation and
many reports (6, 32, 88, 89) highlighted how this effect is actually underestimated in
surface studies. Moreover, the data we are referring to, while providing very useful
comparison for our novel assay, were obtained from surfaces functionalized in the
opposite way: recMoPrP or shorter peptides were chemically linked on the surface,
without any preferential orientation of the binding sites towards the Fab, that was
added to the solution.
The same experiment was conducted on D18-functionalized patches, but in
this configuration the shorter molecular size is offered as a signature of the recog-
nition, and at low patch saturation the average differential height increase signal is
too low to be detected with sufficient accuracy, in contact mode. At 3 nM recMo-
PrP, the increase in height registered by us on the patch is only of 1.5 nm ± 0.8
nm. Based on the affinity reported in the literature (84) (Kd 1.6 nM), we speculate
that already in the low subnanomolar range the coverage is too loose to produce
a reasonable signal. In fact, the ∆h measured at 3 nM (2 times Kd) is half of the
signal at 300 nM concentration, which is not very far from saturation. This implies
that, in this configuration, at very low concentration, the PrP coverage could not
be enough to generate a sufficiently high topographic signal.
4.3.2 Effect of Changing the Surface Coverage of the NTA
Groups
Since the density of D18 and CloneP probes was expected to play a role in the
biorecognition of recMoPrP, the NTA-patch nanofabrication was varied in the 14 to
450 µM range of grafting concentration, and scan density equal to 1.28 (half than
the density used in the experiment above). After fabrication topographic height
and roughness measurements were performed in both contact and non-contact mode
(NC). We expected NC-AFM measurements to be much less perturbative on immo-
bilized protein, since at low coverage proteins may be more prone to tip-induced
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Figure 4.5: Dose-response curve. - Differential height (∆h recMoPrP, blue curve
and open blue circle) contribution due to recMoPrP(89-230) binding on CloneP
patches. A similar sigmoidal response is recognized from the roughness of the
patch as a function of recMoPrP concentration (gray line, solid circle).
60
4.3 Antibody/recMoPrP(89-230) Recognition as a Function of Protein
Concentration: Apparent Binding Constant Measurements
deformation. A test on a different buffer solution suitable for multiple pH mea-
surements and compatible with protein immobilization was performed. Among the
buffer solutions capable of covering a wider range of pH, a phosphate buffer 50 mM
150 mM NaCl was chosen.
Moving from neutral (7.4) to basic (8.0) pH for imaging purposes, the height of the
NTA-nanopatch at equal fabrication parameters (density of lines and grafting con-
centration) decreased, confirming the trend of electrostatic repulsion between head
groups of the molecules. When functionalizing the NTA nanopatch with CloneP in
phosphate buffer pH 7.4, non contact (NC) measurements in liquid revealed a neg-
ligible increase in height, pointing to an extremely low density of probe. However,
when titrating the surface with increasing concentration of recMoPrP (89-230), spe-
cific immobilization was achieved only on the patches, and the differential increase
in height over the patch due to recMoPrP immobilization was following a sigmoidal
trend, with an apparent affinity constant of 2.0 ± 0.8 nM and 1.6 ± 0.8 nM on
patch fabricated at 450 µM and 143 µM NTA-thiol concentration, respectively (see
Figure 5, panel a). At higher titer of CloneP (625 nM against the usual 300 nM) an
increase of 1.2 nm was detected (on 450 µM NTA-patches), but negligible recogniton
of recMoPrP(89-230) was achieved between 300 pM and 35 nM.
D18 was tested in the same condition (Figure 5, panel b). Despite a negligible
signal of D18 functionalization, patches were responding specifically to increasing
concentration of recMoPrP(89-230). Confirming contact mode measurements, sat-
uration of the nanopatches was not achieved below nanomolar concentration, and
apparent Kd estimation at 450 µM and 90 µM NTA patch fabrication were pointing
to 2.9 ± 1.1 nM and 1.9 ± 1.3 nM, respectively, near the SPR data (84) (1.6 nM).
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Figure 4.6: Dose-response curve of differential height measured in NC mode
- ∆h recMoPrP (blue curve and open blue circle) contribution due to recMoPrP
(89-230) binding on CloneP patches (panel a) and D18 patches (panel b) as a
function of NTA-thiol grafting concentration (scan density equal to 1.28, imaging
buffer 50mM phosphate buffer, 150 mM NaCl, pH 7.4). The estimated Kdapp de-
creases as the grafting concentration –and in turn, Fab density– decreases. How-
ever, especially for D18 functionalized patches, good S/N (Signal-to-Noise) ratios
are achieved for NTA thiol concentration above 90 µM.
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4.4 Effect of pH on recMoPrP Immobilization
In addition to the above experiments recMoPrP(89-230) was captured on Fab
derivatized surfaces at pH 5.8 (20 mM sodium acetate buffer, 150 mM NaCl). This
buffer is similar to the one used for refolding recMoPrP(89-230) into a stable Îś-
helical rich conformation after purification (see Figure 2, panel b). Under these
conditions, NTA patches showed a height increase of 3.2 nm ± 0.4 nm over the
carpet, in agreement with the theoretical value of 3.5 nm, and suggesting a compact
and ordered packing of the thiols, and a screening of the electrostatic repulsion of
the head groups.
Initially, the surface was derivatized with either D18 or CloneP Fab at 300 nM
concentration, showing a differential increase in height of 4.7 nm ± 0.4 nm for
D18 and 3.5 nm ± 0.3 nm for CloneP, in improved agreement with the molecular
size taken from previously published structures, indicating a more compact layer of
probes than in the case of 7.4 pH, as shown in picture 4.7. The difference between
the measured average heights of two antibodies increased, from 0.5 nm at pH 7.4
to 1.2 nm, suggesting a different response of the two molecules to pH variations.
Specific and stable docking on the nanostructures was achieved also at pH 5.8, while
the EG3-SAM remained clean during the assay as the modest variation in roughness
confirmed (between 0.24 nm before any fabrication step, to the 0.6 nm average
roughness of the surface at the end of the assay after recMoPrP immobilization). At
the NTA-fabrication step the roughness of the patch remained relatively smooth
(on average, 0.5 ± 0.1 nm in buffer). It increased as the Fab was immobilized, as
1.2 nm ± 0.4 nm for D18 and 0.6 nm ± 0.3 nm for CloneP, pointing at a possible
lower coverage of the surface in the latter case and confirming the topographic height
data. Subsequently, the patches were exposed independently to a 300 nM solution of
recMoPrP(89-230), and the two Fabs were both able to recognize their antigen. We
measured an average thickness of the recMoPrP layer of 3.6 nm ± 0.5 nm on theD18
patches and of 4.9 nm ± 0.4 nm with the CloneP sublayer, (with a corresponding
roughness of 1.8 nm and 1.1 nm, respectively). Despite the total height after target
capture is almost the same on both patches (due to the different Fab contributions),
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Figure 4.7: Oriented immobilization of recMoPrP(89-230) at pH 5.8 - Oriented
immobilization of recMoPrP(89-230) at pH 5.8 (20mM sodium acetate, 150 mM
NaCl) on D18 (left) and CloneP (right) functionalized patches. Note how the de-
crease in pH affects the assembly of the molecule on the nanostructures. All values
are given ± Standard Deviation, (S.D.), as derived from two independent experi-
ments of four nanopatches each.
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the actual increase due to recMoPrP(89-230) was still confirming the successful
orientation of the protein and its detection through topographic measurements.
We tested same density NTA-nanopatches functionalized with a CloneP incuba-
tion concentration of 625 nM and the height increase due to Fab immobilization
was 4.7 nm ± 0.2 nm. This value has to be compared with the 3.5 nm ± 0.3 nm
obtained at 300nM CloneP concentration, which is consistent with a higher number
of Fab molecules being immobilized at higher incubation concentration. However,
the recognition of recMoPrP by the CloneP surface was definitely worse, since the
recMoPrP layer thickness was only 1.6 nm ± 0.3 nm, suggesting the presence of
steric hindrance. Moreover, considering the isoelectric point of PrP, near 9, and
the uneven distribution of charges revealed at pH 4.5 by NMR (86), an electrostatic
impairment to the proper assembly of PrP molecules on the Fab surfaces is expected
to play role (86). A dramatic decrease in affinity of the antibody towards the recMo-
PrP can be safely excluded, since antibodies were extensively tested in cell culture
and under physiological condition, and so was also excluded the instability of the
chelating chemistry at this pH. In fact, pH 5.8 is more than one unit above the pKa
of carboxylic acid, that contributes in their ionized form to the coordination of Ni2+;
on the other hand, the pKa of bare histidines is 6.01 (85) that is, on average in this
environmental condition, slightly more than half of the histidines presents one of the
imidazole’ nitrogen in protonated form and unable to coordinate the nickel ion. It
is however known that the pKa of the imidazolic ring of histidines changes depend-
ing on the local environment condition, and that a high local density of NTA-Ni2+
moieties (like our case) favors a faster re-binding in case of transient dissociation of
histidines (49).
Our nanostructured interfaces offer an extremely dense patch of NTA-thiols to
the his-tagged proteins compared to conventional self-assembled NTA-monolayers
(54), so that locally each his-tag is surrounded by a large molar excess of freely
available NTA-moieties. A combination of these effects explains the observed sta-
bility of the Fab derivatized surfaces during measurements. In addition we want to
point out that the binding of Fab did not occurred if the NTA patches were not
loaded with Ni2+ ions, and that bound his-tagged probes were specifically displaced
by imidazole washing (acetate buffer supplied with 400 mM imidazole).
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4.5 Towards a versatile parallel platform
The experiments described so far were performed immobilizing either CloneP or
D18 in an independent manner, because NTA-Ni-His-tag system is not suitable to
simultaneous immobilization of His-tagged proteins at the very same time in multiple
location: all the His-tags would recognize indifferently all the NTA-patterns, unless
a precision deposition devices are used. Once functionalized with a single antibody,
however, specific patterns can be regenerated locally, allowing for the creation of a
device in which the two His-tagged Fabs are immobilized side by side in a parallel
format.
Total regeneration of the surface can be achieved after extensive washing with a
400mM imidazole solution, followed by EDTA cleaning, that ensures the removal
of His-tagged bound proteins by competition, or by scanning repetitively the whole
pattern (or a selected area) at a loading force between 3 to 5 nN, and subsequent
rinsing in buffer. As already mentioned by Tinazli et al. (60), erasing molecule from
a NTA-functionalized monolayer doesn’t alter its capture properties, and the area
can be re-functionalized with another His-tagged protein.
We exploited this technique to immobilize in a parallel manner the two antibodies
on the very same surface, side by side, in order to confirm the two binding config-
uration of recMoPrP (89-230), to study the phenomenon as a function of density
on the very same surface. We chose pH 5.8 to achieve a more efficient regeneration
of the patches. In addition, we tested the prion protein functionalized surface as a
platform for additional biochemical studies such as the study of enzymatic digestion
of proteins.
An array of NTA-nanopatterns was nanografted varying the density of grafting
lines within each pattern. An example of such array is given in figure 4.8. In this
way the local density of NTA within each line is the same, since it depends only on
the grafting concentration when the grafted lines do not overlap, but the efficiency
of substitution in the overall area of the pattern is changed as the tip “writes” fewer
lines. Pairs of patches were produced with the same density, with ratio between
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Figure 4.8: Multidensity array. - Pairs of patches have been nanografted at vari-
able surface density ratio.
scanned and actual area of the pattern ranging from below one (separated lines i.e.
the regime described above) up to where each portion of the surface was “written
over” 5.12 times, were produced.
Patterns were functionalized with D18 Fab, measured, then at each density D18
Fab was “tip-erased” from one of the two patterns (as shown in figure 4.9, and the
regenerated surface was measured and re-functionalized with CloneP. The array pre-
sented pairs of equal density patterns, one derivatized with D18 and one derivatized
with CloneP. Binding of recMoPrP (89-230) 300nM was followed on both antibodies
and at different densities. The ∆h due to rec MoPrP (89-230) in the two configura-
tions is presented in figure 4.10 a and b: while the ∆h over CloneP smoothly increase
increasing the density, recMoPrP (89-230) suffered at higher density of probes when
oriented on D18. The accessibility of binding sites affects the biorecognition and
therefore is dependent on packing. CloneP recognizes an epitope on the portion of
the unstructured N-terminal part of the prion protein: by immobilizing via CloneP
the truncated PrP, the small portion of this flexible arm was hidden to the solution
and the surrounding molecules. This portion is not masked on D18-functionalized
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Figure 4.9: Tip-mediated patch regeneration. - Scanning at moderate force
and higher speed, patches can be cleaned and the NTA functionality is presented
afresh for another immobilization step.
patterns and possibly its fluctuations in time and space ask for a different reorga-
nization of the proteins molecules on the nanopattern, were the local concentration
of molecules was very high. Moreover, the charge distribution at low pH (4.5) re-
vealed by NMR (86) on human prion protein was uneven –it almost showed two
differently charged “faces”– and suggested an electrostatic repulsion contribution to
the assembly on the nanopattern).
Enzymatic reaction The nanoarrays were then regenerated via Proteinase K
(PK) treatment. PK is a serine protease, an enzyme that catalyzes digestion of a
broad spectrum of proteins, used to discriminate the misfolded core of PrPsc since
it is resistant to PK treatment. PK treatment of the nanopattern was supposed to
regenerate the whole array (both refolded recMoPrP and Fabs are substrates for the
PK enzyme), at slightly different rate depending on the total amount of protein on
each nanopattern, as shown in figX: after 1.5 hrs, low density patch were already
regenerated to the (almost) clean NTA-surface, while higher density pattern were
still unhomogeneously rough (roughness rising from 1.6 nm at lowest density and 3.8
nm at higher density) and their height revealed a thick layer of protein deposited.
After additional 14 hrs, almost all the patches were regenerated to the NTA level.
Eventually, a time controlled PK digestion on surface in which a mixture of PrPc and
PrPsc is captured, like from biological specimen, would serve as a tool to identify on
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4.5 Towards a versatile parallel platform
Figure 4.10: Pseudoparallel assay configuration. - A pseudo parallel assay
is performed: after D18 functionalization, one of the pattern per each pair was
“cleaned” by scanning at moderate force and higher speed CloneP was immo-
bilized on the free nanopattern. Panel a) and b) show respectively the results
on D18-functionalized patterns and CloneP functionalized patterns, and the pro-
teinase two step cleaning as a function of nanopattern density: the decreasing
number of fabrication lines reduces the total amount of protein immobilized and the
proteolytic cleavage is more efficient.
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the nanopatches the region in which the misfolded prion resistant to PK digestion
is immobilized.
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5Perspectives
We have demonstrated the oriented immobilization of recMoPrP molecule at
the nanoscale and the measurement of the effect of confinement on biorecogni-
tion combining nanografting, bioaffinity immobilization and differential height mea-
surements using an AFM based platform. Nanografting has been used previously
(61, 62, 63, 65, 66, 67, 76) to study the effect of patterning of protein on the sur-
face in different configurations, but with very little attention on the performance
of the bound macromolecules in a recognition-based assay. The specific receptor
protein orientation has to be homogeneous, the surface roughness should not mask
or affect the binding site accessibility from the solution and the incubation times
have to be sufficiently long to approach equilibrium and to be chosen accordingly to
the characteristic kinetic constants of the molecule under investigation. In this way
the performance of the nanostructured surface can be tested in a quasi-quantitative
assay.
Nanografting of NTA-terminated thiol provides a very general route for specific
protein immobilization in a controlled orientation, since the polyhistidine tag can
be genetically engineered in recombinant protein in a known position, and the inter-
action with Ni-NTA complex is specific. Moreover, this immobilization is reversible
and ensure re-usability of the surface. The nanografted NTA-Ni-His-tag system on
a flat protein repellent reference carpet generates an homogenous surface in which
the His-tagged fragments of antibodies are immobilized to maximize the distribution
of the binding sites towards the solution containing the target protein. Choosing
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Fabs, like D18 and CloneP, allowed for the orientation of recMoPrP(89-230), since
their binding sites are on different locations on the PrP surface. The two differ-
ent configurations (CloneP immobilized recMoPrP(89-230) and D18-immobilized
recMoPrP(89-230)) are discriminated by accurate measurements of the molecular
size of the protein.
The minimum signal detectable from recMoPrP(89-230) binding was in the tens of
picomolar, a value that depends less on diffusion-limited kinetics than on the affin-
ity constant of the antibody, the latter, being in the subnanomolar range, does not
allow for saturation of the nanostructure in the low picomolar range. Unfortunately,
due to safety concern, we couldn’t test our devices with infectious prion sample.
Nonetheless, we expect that a highly controllable surface with specific protein orien-
tation would be very useful in the reliable testing of recognition and binding between
biomolecules. Even though infectious prion concentration in peripheral blood and
tissue is reported to be in the low fM range, successful detection with subnanomo-
lar affinity antibodies could still be possible after proper sample treatment, like
Protein Misfolding Ciclic Amplification (PMCA) (90), or specific sample increased
concentration that, combined with the low volume consumption of this assay, would
circumvent diffusion and affinity limits of the system. Finally we would like to note
that our AFM-based tools have still an enormous potential, as we can speculate that
converging efforts on parallel functionalization, diffusion enhancing system, centrifu-
gal molecule focussing, high affinity antibody and last but not least tethered double
binding molecules could further lower detection limits. A practical and lower cost
version of our device will rest instead on the application of an easier to multiplex
electrical readout system.
In addition to possible diagnostics applications, the strict control over PrP ori-
entation opens many avenues of investigation of possible interacting partners, from
large macromolecular complexes to small organic dyes that interact unconvention-
ally with unfolded proteins (91) and may serve as a platform for protein misfolding
studies on PrP and other thermodynamically unstable proteins. In particular, this
oriented nanoconfinement of PrP, whether in its truncated or full lenght from, can
be used for in situ fibrillation studies, in which the early stage of aggregation can
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be followed in real time with high sensitivity as a function of multiple variable in a
highly controllable environment. The use of antibodies that mask different regions
of the PrP offers the advantage of understanding the assembly and interaction of
proteins during fibrillation by varying the exposed region of the protein available
for protein interaction. Other unstructured proteins, like α-synuclein, β-amyloid
peptide, hungtintin,(92), offer intriguing example to test how the nanoconfinement
can provide a useful, highly controllable environment for misfolding and aggregation
studies on surfaces.
The expertise acquired during the completion of this thesis is now the point of
departure for an integrated approach to nano-confinement of unstructured proteins
as the substrate for a novel approach to biochemical characterization.
Technically, the know-how for both DNA and NTA nanografting based protein
immobilization will be combined to exploit the extreme selectivity and paralleliz-
ability of the former with the versatility of the latter. Specifically, we are now using
a ssDNA-NTA conjugate, kindly provided by Dr. L. Fruk (Karlsrhue University,
Germany), to transform our nanografted DNA arrays into a protein platform with
the added opportunity to immobilize in an oriented manner through the histidine
tag an enormous variety of proteins. The delicate step in this new protocol is the
careful preparation of the Protein-His-Tag Ni2+-NTA-ssDNA complex in such a way
that both the Ni2+ and the ssDNA do not promote and participate in any unspe-
cific interaction with the target protein. Our preliminary results are suggesting that
few percentage of imidazole and salt concentration (NaCl) above 150 mM help in
preventing unspecific interactions when complexes with CloneP or N-terminal His-
tagged-α-synuclein are involved and condition are being optimized and compared
with the standard NTA protocol. Multiple mutant of α-synuclein can then be im-
mobilized on the same surface (thanks to the specificity and selectivity of DNA
hybridization) and then tested, for example, for the binding with new drug lead.
As the work of Staii (61, 65) successfully demonstrated, AFM can detect the
binding of small molecule monitoring the variation in the frictional force between the
tip and the protein as the ligand binds, over a large dynamic range of concentration.
It could be very helpful in characterizing interaction involving “non conventional”
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binding sites (that is, the lack of a well defined binding cleft, suggesting either a con-
formational rearrangement to create the pocket or a “diffuse” location distinguished
only by the nature of the intermolecular force involved, or both). The presence of
an unstructured protein, like α-synuclein, that can experience extreme fluctuation
in conformation, introduces higher degree of complexity in the application of lateral
force microscopy to the screening of potential ligands. Nevertheless, we expect that
the use of friction force microscopy will reveal with enhanced sensitivity the binding
of molecules like dopamine to α-synuclein, and by reflecting the proximity interac-
tion between tip and sample, transient intra- and inter-molecular interaction will be
detected.
We are also aware that the presence of a divalent transition metal ion may be
the source of uncontrolled influences on the folding and on the surface deposition
itself when IDPs are involved (as metal cation are known to interfere with them),
so we aim at linking α-synuclein to gold via the introduction of a cysteine tag, too.
Last but not least, in the framework of characterizing protein-ligand interactions
through interfacial properties, we plan the use of SAM to supply an artificial lipid
membrane for the study of α-synuclein interaction with lipids and lipid induced
refolding, and eventual oligomer-driven pore-membrane formation. α-synuclein, im-
plicated in the etiology of Parkinson’s disease, shows an intrinsically disordered free
state, characterized in its conformational pathway via Force Spectroscopy studies
(93, 94), and via surface characterization of oligomeric states, and with a profusion
of in vitro and in vivo techniques. Upon self assembly into fibrils or binding to
lipid membranes or detergent micelles partial order, residual secondary structure
and transient long-range interactions within the free state can be detected and may
influence alpha-synuclein aggregation pathways. We expect that confinement at the
nanoscale in controlled microenvironment of this protein may bring forth new and,
perhaps, unexpected details that can help elucidating puzzling and obscure aspect
of its physiological and pathological role.
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Materials and Instrumentation
EG3-thiols (HS-(CH2)11-EG3-OH, 2-2-[2-(1-mercaptoundec-11-yloxy)-ethoxy]-ethoxy-
ethanol) was purchased from Prochimia Surfaces (Poland), NTA-EG3-(CH2)16-SH
(2-2-[2-(1-mercaptohexadec-16-yloxy)-ethoxy]-ethoxy-ethoxy nitrilotriacetic acid) was
kindly provided by Jacob Piehler. NaCl, imidazole, EDTA, NiCl2, TRIS, sodium
phosphate dibasic, potassium phosphate monobasic, ethanol (99.8% purity) were
all provided by Fluka and Sigma Aldrich, (Milan, Italy). All the solutions were
prepared in ultrapure 18.2 MΩcm water (Milli-Q, Millipore SpA, Milan, Italy), and
filtered with a sterile syringe-filter (0.22 µm) immediately prior to use. All other
reagents were of analytical grade. All AFM experiments were carried out with con-
ventional AFMs using a XE-100 (Park System, former PSIA, Korea) working in con-
tact mode; Non-Contact mode measurements in liquid were performed on a MFP3D
Stand Alone AFM, (Asylum Reasearch, Santa Barbara, U.S.A.). For nanografting
and NC-AFM imaging, commercially available silicon cantilevers (NSC19, Mikro-
Masch, Poland, nominal spring constant 0.6nN
nm
, tip radius <10 nm) were chosen.
For CM-AFM imaging purposes, a soft cantilever (CSC38B, MikroMasch, Poland,
nominal spring constant 0.03nN
nm
, tip radius <10 nm) was used.
Protein Production and Purification
The Fabs, D18 and CloneP, were produced as previously reported with a (His-
Gly)6 tag (70, 84). The recMoPrP(89-230) was produced and purified as reported
previously(10). All the protein stocks were kept on ice if needed and diluted imme-
diately prior to use.
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Substrate and Monolayer preparation
Ultra flat gold films substrates were prepared using a modified Ulman procedure
(40, 41, 43). Briefly, freshly cleaved mica sheets (clear ruby muscovite, Goodfellow
Cambridge Limited, Huntingdon, England) were mounted in an electron beam gold
evaporator and gold films were deposited at a rate of ∼0.1 nm/s and a chamber
pressure of about 10−6 mbar until a thickness of 100 nm was reached. Small amount
of SU8-100 (MicroChem Corp., MA, USA) polymer were then equally dropped on
the gold side of the gold-mica sheet, and the polymer was then cured (baked 5 hours
at 95◦ C, exposed 20 minutes under a 70 µW/cm2, 462 nm UV lamp, and baked at
least hours at 95◦C, sample for contact mode measurements).
With a similar approach, gold was evaporated on silicon wafers (University
Wafers, MA, USA). Then, cleaned silicon slides of 5×5 mm2 were glued to the
gold surface using small amount of SU8-100, that was cured a few hours at 135◦C.
The SU8-drop, now looking as a flat hard surface strongly attached to the gold layer,
can in this way be mechanically detached in air from the mica substrate, keeping
the gold film attached to it and exposing now the gold surface originally buried at
the interface with the mica. Such Au film surface has the advantage of reproducing
the flatness of mica, giving an extremely reduced roughness of about 4Å(even when
evaporated on silicon).
Samples are, immediately after stripping, soaked in a freshly prepared 300 µM
solution of EG3-thiol in ethanol. The substrates were kept in the thiol solution
overnight in the dark at room temperature. In this way an ultra flat surface cov-
ered with EG3-terminated thiols was obtained. AFM test measurements confirmed
a roughness in the range of 3-4 Å.
The Nanofabrication Process
. In all the experiments the process of nanografting was performed in the fol-
lowing steps.
• (a) A freshly prepared SAM substrate was mounted in a closed liquid cell.
Prior to grafting a worn out cantilever was used to scratch a sign into the gold
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surface, that allows the optical alignment of the cantilever to a coordinate
system which facilitates finding back the nanopatches.
• (b) The liquid cell was filled with the nanografting solution (e.g. a 450 µM
NTA-thiol HS-(CH2)16-EG3-NTA) solution. The SAM was imaged in liquid at
low load to select the area where to fabricate the nanostructures.
• (c) The desired patches were obtained within the SAM by scanning the AFM
tip above a threshold of about 70 nN, with a scan rate of 2 Hz. In this way the
alkylthiol SAM phase was locally disrupted and immediately exchanged with
the NTA-thiol monolayer phase. Varying the number of lines scanned by the
tip during the nanografting patterning varies the actual area scanned by the
tip (and where the substitution takes place): the area effectively substituted
is estimated as the ratio between the area scanned (given by the contact area
of the tip —10 nm— by the number of scanned lines) and the image area:
Rtip · lines/area. The best homogeneous NTA-patches were produced with a
patch size of 500×500 nm2 (i.e. 128 lines S/A 2.56) or 1×1 µm2, (256 lines,
S/A 2.56), and a scan rate of 2 Hz.
• d) After the grafting procedure, the patches were imaged in ethanol and af-
terward in buffer (with a soft cantilever and at low forces, namely below 0.3
nN) in order to record topographic, i.e. height, data. Size of the patches was
chosen to be between 0.25 µm2 and 1 µM2.
Pattern Functionalization
After the nanofabrication process the surface was throughly rinsed with ethanol
and dried. The sample was first washed with a 0.5 M EDTA (EthyleneDiamineTe-
traAcetic Acid, pH 8.6, Fluka) solution in order to remove undesired metal ions, with
three washing step of 4 min each, and a solution containing 10 mM NiCl2 (Fluka)
in 20 mM TRIS, pH 7.4 (Fluka), was loaded on the sample for 5 min. The surface
was then ready for the immobilization of the histidine tagged Fab âĂŞ–CloneP or
D18–âĂŞ able to recognize the recMoPrP(89-230). The Fab has been added into the
AFM liquid cell as a 300 nM solution in 20 mM TRIS 150 mM NaCl (Fluka) buffer
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(pH 7.4) for 20 min. Height measurements revealed the presence of higher patches
on the surrounding surface. No Fabs immobilization was achieved if the NTA surface
was not loaded with Ni(II). Once the surface was functionalized and characterized,
it was incubated at room temperature in a solution containing recMoPrP(89-230) at
300 nM concentration for 30 min. The presence of the molecule was then ascertained
through height measurements after rinsing the surface in buffer.
Regeneration of the surface (removal of the PrP and the Fab) was achieved
copiously washing with a solution of 0.4 M imidazole (Fluka) in 20 mM Tris buffer,
and a subsequent washing step with EDTA 0.5 M was performed. The surface was
then ready for another cycle of immobilization and assay measurements. Enzymatic
surface regeneration was performed incubating the surface with a 100 µg/mL (50
mM Tris, 10 mM CaCl2, pH 7.4) Proteinase K solution (recombinant, PCR grade,
La Roche Diagnostics, Germany) for 90 min and 14 hours. Regeneration of the sur-
face through denaturation of the interaction between the Fabs and the recMoPrP,
with either low pH (pH 4) or denaturant (4M urea) treatment, was abandoned since
it was damaging the surrounding EG3-carpet. In the case of covalent immobiliza-
tion of recMoPrP, HS-C15-COOH 100 µM was nanografted into EG3-thiol. Then,
the surface was activated for 15 min in a solution containing 5 mM DCC (N,N’-
dicyclohexylcarbodiimide) and 15 mM NHS (N-Hydroxysuccinimide) in Tris Buffer
20 mM, pH 7.4, and then incubated for 50 min with a 216 nM solution of recMoPrP
(89-230) or a 30 nM solution.
Binding Studies
Different concentrations of recMoPrP(89-230) above and below the Kd (0.5 nM)
of each antibody were tested, and the differential height were used as the response
signal and fitted to a three parameter sigmoidal dose response equation in Igor Pro
(Wavemetrics, Inc.) through Visual Enzymics 2010 (Softzymics, Inc., NJ, USA). The
topographic measurements were performed after an incubation in the recMoPrP(89-
230) solution long enough to reach equilibrium. The incubation time was estimated
as previously discussed in section 2.3.2.
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Image Analysis
Each experiment involves the fabrication of multiple patches that contribute to
the single experiment statistic, and to the inter-experiments statistics. All height
measurements are reported with their standard deviations. Topographic images of
the patches are then analyzed in term of pixel distribution (region analysis) in order
to get the height value related to the patch at each single step of the experiment
(nanografting, Fab functionalization, recMoPrP loading, regeneration step). The
AFM instrument proprietary software (XEI, Park System, and MFP3D, Asylum
Research) and free open source software, Gwyddion (www.gwyddion.net), were used.
The experimental value was then compared to the global size of the molecule as
obtained from pdb files (1hh0, for Fabs, 1ag2.pdb, 1qm0.pdb for recMoPrP(89-
230), visualized with PyMol, Schrodinger, LLC., http://www.pymol.org).
The height of the patches is the relative height increase due to the nanostructure
compared to the surrounding reference surface (SAM). Then, this height increase can
be related to the fabrication and the recognition events that take place on the sensor
surface as a differential height measurement. For example, the NTA patches are 2.3
± 0.3 nm taller than the surrounding SAM (compatible with theoretical height: from
CRC Handbook of Chemistry and Physics, (85)) bond length value were computed
and corrected by the bond angle between Au-S-C and C-C-C of 109.5◦ and by the
tilting of 30◦ of thiols in self assembled monolayer: a 3.5 nm difference). After the
immobilization of the Fab, the patches are now 4.1 nm higher than the reference
carpet. This relative height increase is due both to the contribution of the NTA-
thiols (2.3 nm) and the Fab (4.1 nm − 2.3 nm = 1.8 nm). Error was propagated as
geometric sum.
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